{
  "doc_id": "non_small_cell_lung_NL",
  "created_date": "2012",
  "country": "NL",
  "source_type": "clinical_guideline",
  "chunks": [
    {
      "heading": "",
      "text": "Veronica: Nie © 2012 - of of Specialists- nca. nca.",
      "start_page": 1,
      "end_page": 4
    },
    {
      "heading": "Startpage - Lung Lung Carcinoma",
      "text": "this this guideline? following following topics: Directive Directive intended?. patients patients . carcinoma carcinoma - module module 'Epidemiology and pathogenesis' assessed assessed : 10-authorized authorized : 10-large large [Damhuis 1996(1); Janssen-Heijnen 1998(4)]. J J 9:97- lung lung carcinoma? NLST NLST 2011(3) groups groups (discontinued discontinued ≤ago ago __MENTERM223; smoking) Trial Trial (NLST)assessed assessed : 10-authorized authorized : 10-the the mediastinum? FDG FDG -CT CT __AGETERTM223; the ADCT-Dentation-Ascending-Center-Lessin-19 19 microSivert/manufactured manufactured (of of ~_EDTERM22_'s combined specificity-PET-FDG FDG -PET-PET-CT PET-CT is: study study __METM223(the the FDG-thoracotomies thoracotomies (19) interpretation (20), FDG FDG -reported reported (21). found found (22). FDG FDG PET-positive positive (_MEDTERM223_abole activity) the the 100% abnormalities abnormalities > 15 mm (5). The combined sensitivity/intra-abdominal intra-abdominal (liver, adrenals) vessel'value value (28). nodule nodule (< 1 cm) is seen; assessed assessed : 22-authorized authorized : 2/2-loss loss >10% and/score score >2 hematocrit <men, men, <Level Level 2: added added (6). group group (7% versus 3%; p=0.04), in in open- treatments treatments (8). is is (e.g., hypercalcemia), MRI MRI (respectively respectively density_METM223) liver_MEDTERM223_sastases liver_MEDTERM223_sastases (of of patients' no no value; Level Level 1: 2003, 2003, (1) Silvestri 1995, (2) Hillers 1994; (4) 2002. 2002. (5) modalities modalities (1) (2). means means (Guidelines Guidelines 2003). assessed assessed : 22-authorized authorized : 20-and and (suspected) function function (FEV and/or TLCO < 80% of predicted) function function (TLSO TLSO ppo) TLulation_MEDERM223___hode TLulation_MEDERM223___hode (scan scan combined;_ (23) following following evidences: VO Max > 20 mL/min/kg: the the lung'smaller smaller resections; perfusion perfusion scan: of of lung/min /kg: lung lung surgery: of of 4%: 8% and and 3% resections resections (1). mortality mortality (2) 7. 7.5% Figure Figure 1: FEV FEV = TLCO TLCO = VO VO = remaining remaining lobe(is is >40% ppo ppo > 40%, resection resection (14) (16) (21) (22) (24). ppo ppo < 30% both both FEV'are are <40% elevated elevated (14) (21/) (25) (26) (27)). max max < 10 mL/min/of of 30-100%. found found (35). patients patients );MDTM223; FEV FEV (2.5-3 l) or or chemo- and/assessed assessed : 22-thepatient thepatient : 2/the the Jonkers' lung-disposed lung-disposed natures? Cardiovascular Cardiovascular Society'this this disease? or or disease? a a intestine-disease-dissolvedness-disability-disappearance-displacement-dispense-discomfort-disposition-disordered?the the patient'patient patient el) Nicholson Nicholson 2010(25); Bishop 2012(74); Mukhopadhyay 2011(83); Nonaka 2012(84); Pelosi 2011(86); Pelosi 2012(85); Thunnissen 2012(93), Travis 2013(94), Tacha_ 2014(92) adequate adequate staging? each each other'shown shown ___MEPTRM2(described described [Nosotti 2005(7 7 and/for for adenocarcinoma' p63-positivity p63-positivity ___MEDTM5?occur occur (T3), occurrence occurrence (T4), 1. 1. T1-the the (15) a a ́Level Level 3: 2003 2003 (63) and and (65) and and 42%. Level 3: 1994, 1994, (53) Mathisen 1991, (51) Tsuchiya 1990 (52) done done (1) (4) (5) (6). a a T1N0- function function ́of of T1-a a segment- to to 69% (2) (12) (13). radiotherapy radiotherapy ( 5. 5.8% lobectomy lobectomy (31). resection resection (repeat repeat resection) a a double- of of 5-year- 5-years- Years- survivorship survivorship 'operated operated (in%) parietal parietal joint' II II Sleeve'- 55 55 - 7 7 - 53 53 - 30 30 - 83 83 ence' melen melen d), ve ve T4-tumors; is is rare: patients patients (43). is is limited: is is 20%. Resection en bloc' marlex-prosthesis marlex-prosthesis (44) (45) survival survival (53) (54). 23 23 (15-31) 42 42 (nv) 0 0 (nnv) 7 7 (ntv) unit unit . Late-to-late-towards-disabled, on-Surg Surg 90:3 3 - high-risk high-risk patient's. Lung ́indicated. indicated. ? distance distance (3) (4) (10) (11) (12) (13). factor factor (p=0.04) (14). statistical statistical power' data data (6). cm cm (2) (18) gross-assessment gross-assessment (21) (21). was was 94% of of 90% (nodes nodes (29) (31) (33) (34). of of N- nodes nodes (T3) the the Lung's presence (Several mediastinal node'the the ?45's baseline ́. prognosis prognosis (46) (47) (52) (49) (50). significant significant (outcome outcome (50). carcinomatosis carcinomatosis (40). assay assay (__MEDTERM223_using __MEDTERM223_using froze-review review reference- Sensiti- lymph lymph node'velocities. velocities. # of of (in %) Coupee Coupee HE- 1993 1993 (21) prospectively coloured paraffin- Comparing, Comparing, 81* Freeze-Coupe: 1989 (22) Retrospective Nero-colored Hose- 0. 0.7%; ng ng ngly-noggly-neg lydally-pole? Not droopyelly-columbars' esophagus-Lumpy Lung (1 1 - Surg Surg 72:2 2 - Thorac Thorac Cardiovasc's stage . *(surgical surgical complexity) **expression. expression. *(The The Netherlands) of of Adjumed'of of Adjunct/adjuvant adjuvant chemotherapy/medert/remnant-free treatment (Adjuter/M MED/therapy therapy .the the agent'the the medication'criteria criteria ._ gewetenTM223; patients patients .the the patient'regimens regimens (__MEDTERM223_confirmed __MEDTERM223_confirmed expression- the the ___METERM642_- and EFS- Targets Targets (KNT) targets targets __MEDTERTM223; 72 72 (95% 56-0. 56-0.93; P = 0.00517) median median {MEPTERN642] compared compared {years years (QALY) of of $of of $46.859/QALY. Das (2023) of of $150,000/ratio ratio of$46.819/Low Low Source: 2022 2022 [CheckMate 816] 2022 2022 [ChiCKMATE 816] Low Low Source: OBrien 2022 [PEARLS / KEYNOTE-091], 2023 2023 [impower010] Low Low Source: O'Brien 2022 [PEARLS/KEYNOTE-091](Felip 2021), Feliplower 20 [Grade-Tropes-Tapper-Topper- Trial Trial (author year 2022) 816 816 (Neoadjurant Neoadjurant __MEDTERM3_Study: group group ́s version ́22 ́27 ́24 ́23 ́15 ́28 ́30 ́20mm 20mm ́29 25m ́. individual individual EQ-confidence confidence (and and anxiety/depression) bias bias (in in RoB). execution execution (of of patients) (levels levels bias) adjuvant___MEDERM3_ adjuvant___MEDERM3_ (480 mg) for 6 months-months months (4-30. 4-30.9). funders funders (and and others) ventricular ventricular rhythm(S). the the __MEDTERM2_-plus- months months (95% CI: 14.3-22.0) group. group. (HR: 0.58; 95% CI: 0.46-0.72; p<plus plus chemotherapy) (in in 19% in in 10% rate rate (Provencio 2023). consciousness consciousness (convulsive level) trial trial (Felip, 2021; Felip, 2023) 589__ 589__ (7th TNM classification) bestes bestes ( life life (Table 6). immunotherapy immunotherapy Trial;author'group group (187/group group (212/498, 43%) (HR: 0.81, 95% CI: 0. 0.99) (Felipest 2021). The PEARLS / months months (95% not not reached) the the patient'or or equal??? (measures measures > relationship relationship (NeoCOAST, NeoCOAST, NCT0310978). durvalumab durvalumab (Neoadj Neoadj (Cascone 2023) (platder Q4W) + __ gewetenM64__ (durvalu durvalu trial) Q2W) (phase II) - NeoadJ. __MENTERM63_ (1300 mg Q4D) +_METERM66_ (750 mg Q2L) - ##+TM63_(1000mg Q4T) + danvatirsen (every every week);chemotherapy chemotherapy Trial; Control Control year'PEARLS PEARLS / __MEDTERM2_ __MEDTERM2_ (KEYNOTE-091 KEYNOTE-091 (phase cycles) + adjuvant chemotherapy (upto 18 cycles)+ adjuva (O'Brien 2022) III) (optional) chemotherapy (apparently) (aptilation) ( 3 - A. A., 6 - relevant relevant benefits: survival survival (85%) events events (73%) (Tsuboi, 2023) months, months, 89% the the {Part Part ́group group (Wu, 2022). Major Major (2022), and and toxicity) and indirectness (means means and/gene gene changes) Institute Institute (ZIN) Netherlands Netherlands (link to advice) GRADE GRADE Sources: (Tsuboi, 2023) survival survival (median 68 months) placebo placebo (median 28 months). Low GRADE Sources: (Wu, 2020; Herbst, 2023); stage stage II-III;MDERM5 Wu (2020) / Majem (2022) / Herbst (2023) / Tsuboi 2023) / John 20223) - months months (WU WU (2020). up up (Herbs Herbs (2023), TSuboi_20] age age (range) was 58 (32-74) were were reported; Feng Feng (2015) - chemotherapy chemotherapy + __MEDTERM116_ group 17/30 (56.7%) with with 18/30 (60%) were were reported; for for _MEDErm36_+ The past & present. Baseline physical/summary summary (PCS/MCS) comparable comparable between;months months (95% be be calculator) months months (95% 35. 35.0) _benzeterM89___group _benzeterM89___group 94/339 (28%) with with 211/34 (62%) were were 43% diarrhea diarrhea (n = 9, 3%), stomatitis (n= 6, 2%), pneumonia (n=1, 1%) evidence evidence (n=0, %) one one (<1%), zero, four (1%), and one (<%) group group (John, 2023). leakage leakage [limitations limitations (-of of level) clinically clinically (patient) importance differences (treatment treatment advice/) where possible): • Overall survival (___MEDTERM642_): >5% HR HR <time time • Disease-free survival (DFS): EGFR-Mutated EGFR-Mutated Non- 2013 2013 Patient'Oct Oct 16;10(10):e014094. doi: 10.1371/0149. 0149. PMID: 26474174; PMCID: PMC460803. 2 - Gos GD, O'5 5 - the the Lung'Adherence-Leaving Adherence-Leaving Detachment: the the chemo-talking talking about? 10. 10.7% 68 68 (95% 0. 0.85). unknown unknown PD- control control (patients patients (their their caregivers) Cost Cost (mean seizure) tumor tumor and/Recommend-2 Recommend-2 Rationale/carcinoma carcinoma (cancer cancer Sources: (Antonia, 2017; Antonia 2018) The safety (and and toxicity) articles articles (Butts, 2014; Mitchells, 2015) chemotherapy chemotherapy (group group together) survival survival (critical outcome) study study (Antonia, 2017); Antonia, 2018) PD PD -chemoradiotherapy chemoradiotherapy (59 59 (95% 0. 0.82) for a PD- 44 44 (95% 0. 0.65) 0. 0.8). 322 322 (67.8%) 125 125 (53.4%) group group (27 27 (95% 1. 1.45)). 56 56 (11.8%) the the 10);graduateM63/10 10 (4.4%) Group Group (76 76 (95% 5. 5.14) 0 0 (22.2%) StART StART -study didn'rate. rate.",
      "start_page": 5,
      "end_page": 177
    },
    {
      "heading": "of of life",
      "text": "Safety Safety (and and toxicity) 2 2 (the the intestine) (care care alone) ( hold hold (risk of bias) imprecision imprecision (patients patients < falling falling apart) (of of life: difference difference (MID) the the ?Q-5D VAS (Medline Medline (via OVID) and Embase (via Embase.com) available available (the the ...- the the ~the the between-the the chemi/dwelling (0. 0.56; 95% 0. 0.70) . TPS TPS <1%, the the assay'a a small-to-of of 2+ study study (Ghandi, 2018) very very limited-tohero-Dose of 1-mg/M-Diner-Diver-biopts biopts PD- a a non- TPS TPS ≥50% patients patients );_ELDERTM245; cell cell ~of of PD- score score ≥of of >10mg prednisone/the the patient's immunopatients' Exclusion Exclusion Criteria: patients patients __MENTERM245; patients patients (their their caregivers) medication medication (Hendrikx, 2017; Freshwater, 2017). services services (care care implementation) MAH MAH Rationale/of of __MEDTERM245_platinum-clinical clinical question: GRADE GRADE Reference: (Gandhi, 2018; Langer, 2016) nonsquamous nonsquamous non-small-cell therapy ( GRADE Referrals: (Govindan, 2017; Lynch, 2012) score score ≥1%. GRADE Referres: (Carbone, 2017); Hellmann, 2018) with with avoidtal- GRADE Reference: (Hellmann, 2018) of of participant'plus plus -following following immunotherapys; __MEDTERM399_ __MEDTERM399_ (label label nonsquamous) Atezo Atezo d- chemotherapy chemotherapy (2). study study (Brahmer, 2017) receive receive either;of of Illness: of of meder'with with youter'old. old. . imprecision imprecision (patients patients <2000 per group) to to equal? (2 2 (3 3 . Langer Langer (22), 13 (22%) the the __MEDTERM0_+ 14 14 (22%) cutoff cutoff (months months (13. 13.3). 59 59 (95% 1. 1.8%), Langer Langer (22), 52 52 (95% CI 0.44), than than 1% was 32.3% versus 14.3% to to 49% 48.4% versus 20.7%. Langer Langer (22), PD PD -less less 1% response response (response rate 57%) 2 2 (2 patient/score) 6. 6.7% (n=27) 5. 5.9% (n=12) death. death. 99% survival survival (critical outcome) chemotherapy chemotherapy 22% evival evival (Govindan, 2017; Lynch, 2012) 84 84 (95% 0. 0.96), favoring __MEDTERM66_ (figure 6). survival survival (or or death) Safety Safety (and and toxicity) __MEDTERM66_+ death. death. (of of death/deaths, death, death/of of ≥5% was was 56% versus versus 54% 02 02 (95% 1. 1.30), patients patients (twice twice daily) (09 09 (95% 1. 1.34), favoring chemotherapy (figure 9). survival survival (or or death) #the the patient's disease; reverse chemotherapy Z: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: study study (Carbone, 2017) Safety Safety (and and toxicity) chemotherapy chemotherapy Z: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: consciousness. consciousness. ( the the patient'the the subject'signature signature (high Teff) WT population (n=284 patients) progestogen ́group group (months months ́S disease) 94. 94.4% 95. 95.4% events events (RR 0.95; 95% 1. 1.02). 55. 55.7% 47. 47.7% group group (RR 1.17; 95% 1. 1.34), chemotherapy chemotherapy Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: questioning questioning (admitting admitting PICO: and and curriculum- select select (Methods) Medline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). table table method(s) 86 86 hits- doi: stage stage IIIB/C/IV_METERM399_? Recommend the patient'the the CDC's self-deprecating agent(S)",
      "start_page": 178,
      "end_page": 235
    },
    {
      "heading": "monotherapy. monotherapy. Severe",
      "text": "therapy therapy (Gandhi, 2018; Paz-Ares, 2021; Reck, 2016; Socinski, 2018). sickle sickle cell's Table 1: Comparison Comparison • median __MEDTERM216_ (PD-L1 < 1%) Patient'the the chemo- PD-L1 PD-L1 expression1% of 1-50% than inpatients-chemo(L1) expression of <1%. GRADE GRADE Source: Hellmann Hellmann (2018) / Brahmer (2023) 227 227 (part 1) analysis analysis (Paz-Ares, 2021; safety safety (Reck, 2021) life life (Rek, 2023); age age (either) (age age (range) was 65 (34-87), 64 (32-84), and 65 (35-85) and and 65%, reported reported effect: of of 23% versus versus 13% PD-L1 PD-L1 <1% cohort (Carbone, langzaam). awaited awaited ( PD-L1 PD-L1 <1% PD PD -of of <1%, rate rate (_MEDTERM228_) was 31.1% (42/135 patients, 95% CI: 39. 39.6) 20. 20.2% (26/1 1 CI: 28. 28.1) months months (Paz-Ares, 2021). for for EQ-and and -029 029 (95% CI: -0. 0.059) CTgroup CTgroup (Reck, 2023); patients patients (94%) chemo-lymphomogeneic chemo-lymphomogeneic ́s disease (Risk of Bias: of of funder); application power (to to indirectness; ease of treatment); inpatients inpatients (imprecision). clinically clinically (patient) importance differences (and and avoidable): group group ≤12 months: Overall survival: >ratio ratio (HR)<group group >12 months and: Overallsurvival: >and and HR<survival survival rate: Shen Shen (2021) on on PD-1/with with CTLA- 4 inhibitors ± number number tested? important important outcomees? evidence evidence (sociological sociological Rationale) subgroup subgroup difference? PD-L1 PD-L1 <1% 4 4 - JAY, JAY, JOWL- the the patient'patients patients (their their caregivers) a a (regional) patients patients ~therapy therapy ; GRADE Reference: (Huang, 2018) advanced advanced non-baseline baseline beam- GRADE Reference Literacy: (Fehrenbacher, 2018; Huang, 2018) advanced advanced non-orthopedics. orthopedics. (Fehrenbacher's, 2018); of of ?_ Horn (2017) and Vokes (2018) CheCKMate-057 CheCKMate-057 trials- functioneel. Fehrenbacher(2018) following following immunotherapys; __MEDTERM3_ (854 854 patients), __MENTERM46_ (1, 1,200) versus 2 chemiluminescence/m2). 66 66 (95% 0. 0.77) trial trial (subgroup subgroup (equal equal equal? . trial trial (18. 18.2% 9. 9.3% group group (RR 1.95; 95% 2. 2.59). Reck Reck (2018) VAS VAS (5. 5.9; 95% 9. 9.7), arms arms (0. 0.034; 95% CI - 0. 0.076). Bordonizumab- had had 83% chemotherapy chemotherapy (RR 0.17; 95% 0. 0.25), had had 59% alone alone ( results results (clinical clinical recurrence) the the patient'as as followes: Overall survivor: >ratio ratio <free free survival:>1 1 - as as second- therapy therapy ( (Akamatsu, 2022; Cai, 2022 ; Herbst, 2022); Reck, 2021 ; Xu, 2022). guidelines guidelines (Hendriks, 2023). arguments. arguments. Patient'chemotherapy chemotherapy (without without treatment) . following following question: chemotherapy chemotherapy (without without treatment) cancer cancer (clinicianly clinicianly (patient) importance differences (where where possible): group group ≤12 month: Overall survival rate: >ratio ratio (HR)<group group >12 months: Overallsurvival: >and and HR<survival survival rate- <=2 cm- References 1 - K. K. __",
      "start_page": 235,
      "end_page": 319
    },
    {
      "heading": "Which (new) _MEDTERM0_ _MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "A A __ELDERTM161*-be be _ELDERM160*Study'therapy therapy (Peng Peng (2023). Follow-up Follow-up (outcome outcome year) bid bid N=bid bid N=pid pid N=62_METM218__~_MEDMTERM229_MEPTERNORM217_Safe_MEMTRM240>MEPTORPH-MEPTR.MEPTORM3-non-PEPTOR M4-MEPTOSTORM1-SEPTOR: sodium-EFTORM4+ sodium Median follow- OS OS I: months months (95% CI: 20.5 C: month month MCER(s): 500 500 mg/died died (30% months months (95% CI: 26.4not reached) estimated estimated 3-year;_MEDTERM218_ was 43% (95% CI: 34%51%) and and 19% (95% CI : 12%27%) _MEDM3_arm _MEDM3_arm (HR = 0.48, 95% CI: 0.350.66). _MEDM218___ _MEDM218___ 36% (26%46%) into the ... crizotinib crizotinib (generation generation TKI) grade grade ≥life life ( insomnia insomnia (the the QLQ-C30) out out what'therapy therapy (_",
      "start_page": 319,
      "end_page": 330
    },
    {
      "heading": "__MEDTERM0_ mutations",
      "text": "Baseline question",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "Which (new) __MEDTERM0_ __MEDTERM0_ mutations?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "incurable incurable LITTERM23___#ADTERM31_ (zedderme) 75 75 mg/following following outcome: survival survival (_MEDTERM38_), overall survival ( Gerber (2018) of of __MEDTERM9_-_- gewetenTerM39_. gewetenTerM39_. • Langen Langen (2023) events events 22% grade ≥56 56 (33%) 61 61 (40%) bias bias (randomization randomization process) and imprecision (OIS not reached). select select module-",
      "start_page": 331,
      "end_page": 334
    },
    {
      "heading": "__MEDTERM0_fusions",
      "text": "Baseline question",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "Which (new) _MEDTERM0_ _MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "study. study. {MMD]treatment treatment (__MEDTERM8_ __MEDTERM8_ (rarely) assessed assessed : 01-01- Last authorized : 24-06- trials trials (RCTs) e. e.",
      "start_page": 335,
      "end_page": 336
    },
    {
      "heading": "__MEDTERM0_fusions",
      "text": "Baseline question",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "Which (new) _MEDTERM0_ _MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "line line __ELDERMW14_~ ongoing ongoing studies--pending pending study--Treatment Treatment incurable__>>>25 25 mg/m=Conclusions Conclusions - and and selection___#MDTERM14_(rarely) assessed assessed : 01-01- ___ ___ °Cntred ___",
      "start_page": 337,
      "end_page": 338
    },
    {
      "heading": "HER2 mutations",
      "text": "Baseline question",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "Which (new) HER2 HER2 mutations?",
      "text": "test test (Conclusions Conclusions - HER2 HER2 mutation/a a HER2-",
      "start_page": 339,
      "end_page": 340
    },
    {
      "heading": "__MEDTERM0_/NRG fusions",
      "text": "Which Which (new) for for __MEDTERM0_/ NRG fusion? module. module.",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "second second line;__DDERM1___ __DDERM1___ (be be collected).",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "NRG:",
      "text": "Conclusions Conclusions - __EDTERM7_ __EDTERM7_ / NRG mutation/Trials Trials (RCTs) the the #1 mutation: candle candle repeat-",
      "start_page": 341,
      "end_page": 342
    },
    {
      "heading": "__MEDTERM0_ mutations",
      "text": "Baseline question",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "Which (new) __MEDTERM0_ __MEDTERM0_ mutations?",
      "text": "of of 41% pretreated pretreated &_MEFTRM46_patients_ISMEDTERTM12_ a _MEPTERNORM13-Study: The patient'Which Which (new) __MEDTERM13_ __MEDTERM13_ mutations? __MDTERM46_ __MDTERM46_ (rarely) assessed assessed : 01-authorized authorized : 24-database. database.",
      "start_page": 343,
      "end_page": 344
    },
    {
      "heading": "BRAF mutations",
      "text": "Baseline question",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "Which (new) BRAF BRAF mutations?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "BRAF V600:",
      "text": "of of __EDTERM0_//a a benefit- Treatment Treatment incurable_>trials trials (__MEDTERM0_ __MEDTERM0_ +a a 68% 20 20 insertion: line_ line_ verwarrenmedTER29___#assessed assessed : 01-authorized authorized : 24-Database. Database.",
      "start_page": 345,
      "end_page": 348
    },
    {
      "heading": "board board __MEDTERM0_",
      "text": "board board (MTB) lung lung cancer(__MEDTERM5_unusual __MEDTERM5_unusual and/genetic genetic changes? be be arranged? board board [MTB] a a (regional) patients patients __MEDTERM5_: targeted targeted therapy; a a patient' consultation consultation (MDO). pathology pathology (KMBP). clinical clinical (molecular) a a physician'the the MTB? predictive predictive testing' cancer cancer (Lindeman, Lindeman, 2018; Garinet, 2018). frequent frequent (mean >5%) affected affected (Tsao, Tsao, 2016; Simon, 2013). MTB-experts MTB-experts up-Dutch Dutch (NVALT-web NVALT-web site) MTB MTB (unknown unknown (combinations of) changes changes (general general <1%) combination combination ~therapy therapy (not not registered/off-label) melanoma melanoma (than than V600E), colorectal carcinoma (NRAS-mutations), multiple multiple (possible) carcinoma carcinoma (the the adenocarcinoma) changes changes (<1%) patients patients met_DFEDERM163_? overall overall condition;be be (___MDertrem5_the ___MDertrem5_the patient) dose dose (10 10 fractions) of of <30 mg/m^dose dose (3 3 Gy) 100 100 mg/ kg/ of of {once], Radiotherapy Radiotherapy ---_MEDTM 5 mg/kg/mg/of of ≥ 10 mg/day (module module (description effects, conclusions) from from 3/2006 2006 (2D 2D ,3D 3D > 2D 2D ? dose dose (question question • patients patients __MENTERM5_patient'concerning concerning diagnostics? • occupational occupational disease? ~ any any patient's face-about about diagnostics? hospital, hospital, and/the the GP/MEDTERM5/ developed developed (by by 2023) Nederland Nederland (VKGN); Pathology Pathology (NVVP) unnecessary unnecessary and/ about about 15% and and 5% mostly mostly (Gibson, 2013). asbestosis asbestosis and/ life life (in employment and/ cancer cancer (Lexcess, 2022). patients patients __MDTM/ nurse nurse consultant/contact contact ___MED/and and (psychosocial) 2021. 2021. (Website: content/uploads/07/physician physician ́the the investigator'protocols protocols (Surgeons Surgeons database) medical medical record: age; gender; tumor tumor (pain, pain, dyspnea); node node swelling; circulation circulation ́s neoplasms (neurological neurological symptoms); be be ('inappropriate' corresponding corresponding performance- a a risk/electronical electronical (or paper) record: Röntgenthhorax phototherapy; Bronchoscopy; CT; mediastinoscopy (these these nodes); FDG-PET-CT; patient's MRI; Lab review- syndrome syndrome (see above); examination examination (value value (FEV ), capacity capacity (TOWER) the the post- study study group'Level Level 3: 1992 1992 (4), Sarna 1998 (1), Zabora 2001 (3), Hopwood 2000 (2) Level Level 1: Inpatients vs. Liter",
      "start_page": 349,
      "end_page": 411
    },
    {
      "heading": "References",
      "text": "1 - 2 2 - Oncol Oncol 18: 3 - the the patient'doctor. doctor. In: Holland JC (ed). St. St. John' _MEDTERM0_ _MEDTERM0_ patients; goes goes (fear and grief). quit quit ~_ Level 3: 2005 2005 (8) affect affect nurse'lonely lonely and/chemotherapy chemotherapy (5). good good quality-time time (6). study study ( preserved preserved family/family relationships (9) (10). chemotherapy chemotherapy (10). study study (n=471) information information (13). desired desired (14). receive receive thepatients' the the caregivers' health health care: and and (oncology)Level Level 3: C Schrameijer (1) the the patient'schuldpleging schuldpleging ( Geneeskundigene Geneeskundigene Raad) also also 'carcinoma carcinoma - be be classified? T T <=four four patterns: a) classified classified separately; b) if if they'both both lungs; c) status status (Bron: Travis, 2008) invasion invasion (Table 2). station station (anatomical location) M1c M1c (Figure Figure 3) (Eberhardt, 2015) status status (Bron: Eberhardts, 2015 ) classification classification (Bron: Distentions_METM Distentions_METM (Bron: Goldstraw, 2016) Stage Stage 1-Tn-Ten-Stum T1 BQ-D-O-N-T-E-L-I-G-C-K-a a 2-M-a a 2-T-Tin-Tine-L0 L0 M0) M0 ?Q0 Q0 L/Q, L-L-O-T-E-R-C-S-A-N-D-Y-G-T. L-H-I-K-U-V-F-T equals L-B-Tube D-Tac-Tank-W-Tengum-Tag-Tang-Oncol. Oncol. May;11(5):666- 3 - Rami-Porta Rami-Porta R; Institutions. Institutions. (2015) Staging Staging Project: Descriptors Descriptors C) staging staging project: 2009 2009 May;4(5):568-77. 8 - LB. LB.",
      "start_page": 411,
      "end_page": 428
    },
    {
      "heading": "headed headed none",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRoad 4: © 2012 - Specialists. Specialists.",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed none (column 1)",
      "text": "Row 1:\n Row 2:\nNie row 3: row 4: © 2012 - 2025Guidelineenda",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed none (column 2)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: row 6: a a pro",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed none (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nIncelRow 5:\n Row 6:\n Row 7:\noduct unders",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed none (column 4)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\ndrool lungcRaw 5: ROW 6: −Row 7:\nsupported by theKennisi",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed none (column 5)",
      "text": "Row 1:\ncarcinomaRow 2:\n Row 3:\nMedical Medical Specialists",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed Start Page - lung lung carcinoma",
      "text": "Page Page 2/ multidisciplinary multidisciplinary committee;RowRow 29:\n Row 30:\non on 23-01-2025 5/428",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed Start Page - lung lung carcinoma (column 1)",
      "text": "Use Use (CHMP) Row Row ́s suspension is: This pack contains: the the studies? multidisciplinary multidisciplinary committee;RowRow 29:\n Row 30:\non on 23-01-2025",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed Start Page - lung lung carcinoma (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: et- row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: - row 14: row 15: row 16: eincel eincel . row row 17: row 18: row 19: row 20: row 21: row 22: row 24: row 25: row 26: row 27: row 28: ew 29: EKT 29:",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed Start Page - lung lung carcinoma (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 25: row 26: row 27: row 28: row row 29: row 30: 5:",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - GeneralRow 3:\n Row 4:\nSee the 'sub sub module'.Row 5:\nRoad 6: ~Row 7:\nResponsibleRow 8:\n?Row 9:\nLast assessed: 10-07-2015 Road 10: Last authorized: 10-07-2015",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 6/428",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - AlgemRow 3:\n Row 4:\nmodule module 'Epidemiology and pathogenesis'Row 5:\nrow 6: ~ row 7: ResponsibleRow 8:\n?Row 9:\nLast assessed: 10-07-2015 Road 10: Last authorized: 10-07-2015",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n1",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\neenRow 3:\n Row 4:\n'.Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\nthe the . Med Med 2001;58:52-61.Row 15:",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\nRowRow 15:\n Row 16:\n6/428",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: shift shift - pathogenesisRow pathogenesisRow 3:\n Row 4:\nEpidemiologyRaw 5: is is diagnosed; in about 70% __MEDTERM6_ __MEDTERM6_ (feb feb 2020). smoking smoking [Molina 2008(7)], diseases diseases (COPD) [Collins 2007(6)], matter matter (phine particles) * following following studies:",
      "start_page": 7,
      "end_page": 7
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: Lately authorised: 10-07-2015",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nRowRow 4:\nrow 5: J J 9:97-",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n6- Lung Lung cancer: management. management. 'Physician Physician 2007; 75(1): 56-63'.Row 2:\n7Row 3:\nProc Proc 2008; 83(5): 584-594.'Row 4:\n8",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n822.'Row 2:\n10 - RowRow 3:\n Row 4:\non on 23-01-2025 8/428",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - ScreeningRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nlung lung carcinoma?Row 7:\n Row 8:\nRecommendationRow 9:\n Row 10:\nRowRow 21:\n Row 22:\nnodules nodules __",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: lung lung carcinoma' ROW 5: discontinued discontinued ≤__MEDTERM0_ __MEDTERM0_ smoking) Trial Trial (NLST) __ELDERM0; specific specific application( study study (1.2%) NLST NLST (23.3%).Row 6:\n Row 7:\nResponsibleRow 8:\n?Row 9:\nLast assessed: 10-07-2015Row 10:\nLast authorized: 10-07-2015",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 10/428",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nrow row 5: row 6: at at __MEDTERM0_? Road 7: ~ row 8: Recommendation row 9: − row 10: _METM0_ _METM0_ . row 11: ≥ row 12: Concern 14:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 11/428",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nrow row 5: row 6: row row 7: ? row 8: Recommend row 9: - row 10: row row 11: − row 12: Considerations row 13: = row 14: row row 15: ~ row 16:Row-2-2: Row-2-5: Row-12:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\narcin row 3:Row 4:\n Row 5:\n Row 6:\ndishond row 7:Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\neschreRow 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n2011Row 21:\n2011 row 22:Row 23:\norderRow 24:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nUncleRow 3:\n Row 4:\n Row 5:\n Row 6:\nderzoeRow 7:\n Row 8:\n Row 9:\n Row 10:\ntitheRow 11:\n Row 12:\n Row 13:\n Row 14:\neven.Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nm - HereditaryRow 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n Row 9:\n Row 10:\neidsonderzoRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\njkheidsoRow 3:\n Row 4:\n Row 5:\n Row 6:\nLC ?Row 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\nunderRow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nCLC.Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nentualRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\nrzoeRow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\nekRow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nverraRow 22:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 10)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: produ row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 12)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: guess row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 13)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23: 11/428",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - DiagnosisRow 3:\n Row 4:\nThe subject 'carcinoma carcinoma diagnosis' modules. modules.'Row 5:\nRoad 6: ResponsibleRow 7:\n~Row 8:\nLast assessed: 22-05-2011Row 9:\nLast authorized: 20.05-2011",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 12/428",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nCancerRaw CancerRaw 2: lungcaRow lungcaRow 3:\n Row 4:\nThe subject 'non small Cell'Row 5:\nRrow 6: ResponsibleROW 7: ~Row 8:\nLast assessed: 22-05-2Row 9:\nLast authorized: Road Road 10: −Row 11:\nRay Ray 12: =Row 13:\non on 23-01-2025",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\narcin row 3:Row 4:\nrow row 5:Row 6:\n Row 7:\n Row 8:\n2011Row 9:\n2011 row 10:Row 11:\norderRow 12:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nuncle row 3: row 4: gcarcin row 5: row 6: row 7: row 8: row 9: row row 10: row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nm - DiagnRow 3:\n Row 4:\nnoom-diagnRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\nnostalgiaRow 3:\n Row 4:\nnostius' woRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\npeelle row 5:Row 6:\n Row 7:\n Row 8:\n Row 9:\nprodu row 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 10)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\nes.ROW 5: ROW 6: ~Row 7:\n−Row 8:\n4)Row 9:\ntheRaw theRaw 10: =Row 11:\n12/428",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nRowRow 5:\nrow 6: met___ met___ {RowRow 8:\nRecommendRow 9:\n~Row 10:\nis is thirteen-:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 13/428",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nrow 6: aff aff nmet_",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\narcinomaRow 3:\n Row 4:\n Row 5:\n Row 6:\nrow row 7:Row 8:\n Row 9:\n Row 10:\nrow row 11:Row 12:\n Row 13:\n Row 14:\nWritten.Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n2011Row 21:\n2011",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nRowRow 2:\nrow 3:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nm - AnamRow 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\nlichaRow 3:\n Row 4:\n Row 5:\n Row 6:\noutvoRow 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nentualRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\nameRow 3:\n Row 4:\n Row 5:\n Row 6:\nrow row 7:Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\n Row 6:\nrow row 7:Row 8:\n Row 9:\n Row 10:\nerboeRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nverwaiRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\nondeRow 3:\n Row 4:\n Row 5:\n Row 6:\nchameRow 7:\n Row 8:\n Row 9:\n Row 10:\nduck.Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\nerzoeRow 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nproduRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 10)",
      "text": "Row 1:\n Row 2:\nekRow 3:\n Row 4:\n Row 5:\n Row 6:\nunderzRow 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\nRowRow 22:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: guess row 22: row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 12)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow 4: row 5: row 6: row row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23: 13/428",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Rrow Rrow 3: Raw 4 : imaging imaging (Row 5:\n Row 6:\nRough Rough 8: RecommendationRow 9:\n− ROW 10: ~ is is 67-88% tomography tomography (CT) be be performed",
      "start_page": 14,
      "end_page": 14
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\na a short-axis-dia_MENTERM0_er > IASLC IASLC (Lung Lung Cancer) Tumors Tumors (RECIST) to to (www.eortc.be/recist). maximum maximum dia_>a a 'long' window (WW = 1200-1500, WL = 50-100) the the tumor",
      "start_page": 15,
      "end_page": 15
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nResponsibleRow 4:\nrow 5: Last assessed: 22-05-2011Row 6:\nLast authorized: 20.05-2011",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 16/428",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nResponsibleRow 4:\nrow 5: Last assessed: 22-05-2Row 6:\nLast authorized: 2/2/2 row 7: row 8: database. database.'Row 9:\n~ row 10: on on 23-01-2025",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n2011Row 6:\n2011",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nRowRow 2:\nrow 3:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nrow row 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nvervainRow 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nrow row 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n16/428",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - FDG-PETRow 3:\n Row 4:\nRowRow 5:\nRoad 6: the the mediastinum? Raw 7: RecommendationRow 9:\n~ ROW 10: Patients Patients ~effective. effective. • FDG FDG -PET; the the fDG-the the Rovange-PET-T-DPM-DQ-Dovest-Gods-",
      "start_page": 17,
      "end_page": 17
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n__MEDTERM0_astases __MEDTERM0_astases (>95%) specificity specificity (approximately 78%) FDG FDG -Level Level 1: A1 Gould 2003; (12) 2008. 2008. (18) The FMD-__OMEPTERM0_a __OMEPTERM0_a _&===4-== ===(==-==>==#==",
      "start_page": 18,
      "end_page": 18
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 18/428",
      "start_page": 18,
      "end_page": 18
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nof of FD-PET-ROW ROW 5: the the FED-PET-CT'of of 92% of of 84%, of of FDG-data data (are are based) a a __",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n__MEDTERM0_astasis __MEDTERM0_astasis 11%. Gould Gould 2(3). the the Natory'the the FMD-brain brain tissue; are are >90% are (5). demonstrating demonstrating brain- and liver_MENTERM0(s) be be a",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nResponsibleRow 4:\nrow 5: Last assessed: 22-05-2011Row 6:\nLast authorized: 20.05-2011",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1905Row 2:\n2",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nMed Med 139:879-892Row 2:\n1",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n348:2500-2507Row 2:\n17 - Lung Lung Cancer: Dual-Modality PET/RowRow 3:\n Row 4:\non on 23-01-2025 21/428",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: Preoperative Staging. 'Radiology 229:RowRow 6:\n1",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1392Row 2:\n2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n22:2357-2362Row 2:\n2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n128:2490-2496Row 2:\n2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n75:231-235Row 2:\n3",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n60:479-492Row 2:\n3",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 22/428",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nIntroduction",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2: RowRow 3:\naspiration aspiration (TBNA) subcarinal subcarinal (station 7; TNM TNM classification) region region ( RowRow 10:\n Row 11:\nResponsibleRow 12:\n-Row 13:\nLast assessed: 22-05-2011Row 14:\nLast authorised: 20.05-2011",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 23/428",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Veronica: VIII VIII (5. 5.1). excipients. excipients.",
      "start_page": 24,
      "end_page": 24
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW ROW 3:Row 4:\nROW ROW 5: techniques techniques (almost) 100% Raw Raw 7: ROW ROW 17: ROW 18: RowTer RowTer (Bosema, 2019) 9. 9.6% and 9.9% endosonography endosonography (combination EU/EBUS) the the results",
      "start_page": 25,
      "end_page": 25
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: Road Road 4: row 5: patients patients (possibly their carers)Row 6:\nAn EBUS/ the the body; the the gullet/ row row 10: following following conditions: the the benefit/this this indication: Raw 15",
      "start_page": 26,
      "end_page": 26
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: : RowRow 5:\ncharacteristics characteristics (in ESTS < NCCN NCCN < and and < 3cm nonsolid tumors), CT CT (< short short axis) ROW ROW 6: mediastinal mediastinal staging: resistance resistance (",
      "start_page": 27,
      "end_page": 27
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: to to EBUS/ lung lung cancer; powder 6: ~Row Rovode 8: ́Sources: (Seghal, 2016)review. review.'Row 17:\n Row 18:\nReview Review (source: )",
      "start_page": 28,
      "end_page": 28
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nSeghal, 2016)Row 2:\nRowRow 3:\n5 5 : avoidable avoidable cm(s) .",
      "start_page": 28,
      "end_page": 28
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: surgery surgery (inoperable inoperable patient), disease disease (respiratory respiratory disease) . VAM VAM (Um, 2015; Zhang, 2012). InRow 26:\non on 23-01-2025 29/428Row 27:",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nlung lung carcinoma'Row 2:\nRowRow 3:\nRow 4 : Row 5 : request request (PET-Rovant, rowd-Rawd-Sp.",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nsurgery surgery (inoperable inoperable patient), RowRow 3:\nRow 4 : failure. failure.",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: mediastinoscopy mediastinoscopy (Annema, 2010; Liberman, 2014). the the EBUS-TBNA/ EUS -FNA (Annema, 2005; Um, 2015; the the hospital",
      "start_page": 30,
      "end_page": 30
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 30/428Row 4:",
      "start_page": 30,
      "end_page": 30
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: ROW 4: RowRow 5:\nRoad 6: ́Row 7:\nRowRow 8:\nand and 91% versus versus 90% group. group. Liberman",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\nlungRaw lungRaw 6: 6. 6.8% (95% 9. 9.8)Rov 7: ROW 8: Table 2Complications EUS/EBUS versus mediastinaloscopy/surgical staging. Source: Seghal (2016) Raw 9: StudyEUS/ EBUSMediastinoscopy Raw 10: Annema",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n6. 6.8% (95% 9. 9.8).Row 4:\nrow 5: Table 2Complications EUS/ EBUS versus mediastinaloscopy/ surgical staging. Source: Seghal (2016) ROW 6: StudyEUS/ EBUSMediastinoscopy Raw 7: Annema",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: 1) row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row row 21: cal row 22: row 23: row 24: row 25: row 26: row 27: row 28: row 29: row 30: row 31: pyeon:",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: C: Mediastinoscopy; andRow 6:\nO:reviewed reviewed (Row 7:\nmeasures measures -Row 9:\ncomplications complications - Routine.",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 33/428",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n4",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 34/428",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n4",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nwith with quez-Row 4:\n Row 5:\n34/428",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW_ION: ROW ROW 2: carcinoma carcinoma - RowRow 3:\n Row 4:\nRaw Raw 5: Road 6: RowRow 8:\nrow row 7: Recommend CPMP/ 3736/ 03 12/ treatments. treatments. ́Row 17:\n Row 18:\nUndergoingRow 19:\n~Row 20:\nConclusionsRow 21:\ń ROW 22: In patients ~ a a ~",
      "start_page": 35,
      "end_page": 35
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nROW ROW 5: loss loss (1). of of ___METM0/CT CT (adrenals, the patient'the the chest/done done (renal renal impairments). a a FDG-PET/first-stage first-stage study",
      "start_page": 36,
      "end_page": 36
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: ROW ROW 5: conclusionf conclusionf (9). demonstrate demonstrate (occulte) carcinoma, carcinoma,",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n4- cancer. cancer. 'Chest 123:S137-146'. 2003.Row 2:\n5",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 37/428Row 2:",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nRoentgenol Roentgenol 168:RowRow 6:\n1",
      "start_page": 38,
      "end_page": 38
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 38/428",
      "start_page": 38,
      "end_page": 38
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nlung lung carcinoma?Row 7:\n Row 8:\nRecommendationRow 9:\n Row 10:\nas as appropriate;is is not",
      "start_page": 39,
      "end_page": 39
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: survival survival (Guidelines Guidelines 2003). with with Row-",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n3- Cancer Cancer biomarkers: into into success?Inst Inst 102:RowRow 2:\n4",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 40/428",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - medical medical (in)operabilityRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nfor for medical(in)operation?Row 7:\n Row 8:\nRecommendationRow 9:\n Row 10:\nAge",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nConsiderationsRow 3:\n Row 4:\nLung function testing",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 41/428",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nvalue value (%pred). function function (FEV and/or TLCO < 80% of predicted) TLSO TLSO ppo) calcification_ISMETM0_hode calcification_ISMETM0_hode (scan scan combined;higher higher risk",
      "start_page": 42,
      "end_page": 42
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\nperfusion perfusion scan/ FEV FEV > 40% is is > 40% dyspnea dyspnea d'FEV FEV < 40% and TLSO < 40% Level Level 3: 1989, (14) 1994, (24) Furguson 1995, (22) have have a",
      "start_page": 42,
      "end_page": 42
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nrow 2:Row 3:\nrow 4: • cancer cancer • was was tried: is is increased: 10, 10,6% 17. 17.8% 8. 8.1% nectomy nectomy (3). perioperative perioperative mortality",
      "start_page": 43,
      "end_page": 43
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nFigure 1: RowRow 7:\n Row 8:\nFEV = TLCO TLCO = max max = functional functional lob'the the pulmonary",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nFigure 1: RowRow 3:\n Row 4:\nFEV = TLCO TLCO = max max = by by the",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nnRow 3:\n Row 4:\norder ben) talRow 5:\n44/428",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nROW ROW 6: l l (for a lobectomy: > 1.5 l) (12). above above 80% 1 1 (13). the the 1+QQQ <=of of 34% (28). ppo ppo > 10 2 mL/ min/ ppo ppo < 10 mL/min/ perisurgical perisurgical mortality/ morbidity (14). in in ml/ minute/ into into account;___MEDTERM0_ under-",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1Row 2:\n24",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1Row 2:\n22",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "following following convention:Row 3:\nrow 4: Role 5: cancerarrow cancerarrow 6: of of 35% Plan Plan (RMP) perioperative perioperative re-operation",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nOncol Oncol suppl1: s83-92Row 2:\n6- octogenarians. octogenarians. 'Surg Surg 63:785-789', 1997.Row 3:\n7- Elderly. Elderly. 'J J 33:222-288",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 46/428",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n1",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n31 - morbidity. morbidity. 'Dis Dis 129:730-734', 1984Row 2:\n3",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n3Row 2:\nChest 104:701-704Row 3:\n3",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 47/428",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nIIIA-N2 IIIA-N2 non-Inst Inst 99:442-450; 2007.Row 6:\n99:442-450Row 7:\n Row 8:\non on 23-01-2025 48/428",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nradio radio 99:442-450; 2007.Row 4:\n99:422-450Row 5:\n Row 6:\non on 23-0",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\ninomaRow 2:\n Row 3:\nRowRow 4:\n Row 5:\n01-2025",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nsmall-cRow 4:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n48/428",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nrow row 5: row 6: Which investigations (tumor tumor tissue) targeted targeted therapy?Row 7:\nstudies studies are: Road Road 9: studies studies should",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row Chemical 1:Row 2:\nSubstantiationRow 3:\nrow 4: ConclusionsRow 5:\nRoad 6: adequate adequate staging? Raw 7: RowRow 8:\nassessment assessment and/ of of (occult) nceterM0 -setting setting of",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nVersion 2011/2015Row 2:\nincluding including p40/of of __",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nrow row 5: row 6: Which investigations (targeted targeted therapy?Row 7:\nstudies studies are:Row 8:\n−Row 9:\ncare care unit",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\nSubstantiationRow 3:\nrow 4: ConclusionsRow 5:\nRoad 6: adequate adequate staging? Raw 7: RowRow 8:\nassessment assessment and/ of of (occult) than than rowT",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nVersion 2011/2015Row 2:\nincluding including p40/of of __",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: el) are row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: al row 15: TTF-1 row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row row 24: row 25: row 26: row 27: row 28: row row 29: row 32:",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: know row 24: row 25: row 26: row 27: row 28: row 29: row 30: row row 31: 49/4.",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nLevel 3",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2: RowRow 3:\n Row 4:\nadequate adequate staging? ́ Rov 5: RowRow 6:\nthe the tumor's occurrence(described described [Nosotti 2005(15); Yasumoto 2003(17)], is is a",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nRoad 4: ROW 5: lung lung carcinoma' ROW 6: no WHO-diagnosis-carcinoma, {Captained] and {Backwards] Cryptomegaly.",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n139Row 2:\n3",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 51/428Row 2:",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nOncol Oncol 20:RowRow 6:\n8",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nCancer 18:231-40Row 2:\n1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n34:181-186Row 2:\n1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n76:194-201Row 2:\n1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n115:777-782Row 2:\n1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n20 - cancer. cancer. 'Res Res ;135:167-175,'2007.Row 2:\n2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n867Row 2:\n2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nPathol.41:1536-1543Row 2:\n2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nOncol Oncol 5:436-41Row 2:\n2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 52/428",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n2",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nAnticancer Res 29:2767-2773Row 2:\n3",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n815Row 2:\n3",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nPathol 22:128-133Row 2:\n4",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 53/428",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n4",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRes Res 15:3315-",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nN",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n2007Row 2:\n6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n66 - Pathology. Pathology. 'RowRow 2:\n6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n6'8 - Med Med 120:RowRow 2:\n6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 54/428",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: 2013; 368(25): RowRow 6:\n7 Clin Onco",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n8'0 - adenocarcinoma. adenocarcinoma.'Nat Med 2012; 18(3): 375 377.'Row 2:\n8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n2011; 35: 15 25.'Row 2:\n84 - carcinomas. carcinomas.'Pathol Pathol 2012; 36: 895-899.' Road 3: 8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n290.Row 2:\n8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n8 row 2: Cancer Res 2005; 65(5): 1642-1646.Row 3:\n9",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nMed Med 2013; 137(5): 668-684.Row 2:\n9",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 55/428",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n9",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 56/428",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n9",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nPathol. Pathol. 2013; 37(4): 554-562Row 2:\n Row 3:\non on 23-01-2025",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nuniq uniq .Row 3:\nRowRow 4:\n2.Row 5:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRowRow 4:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nopathoRow 3:\npatholoRow 4:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRowRow 4:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow row 4:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow row 4:Row 5:\n56/428",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\ncarcinoma carcinoma (Synoptic Reporting) is is essential: RowRow 5:\nprotocol protocol Rowman's room:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nMelanomaRow 2:\nRenal-RowRow 3:\nRowRow 4:\nRowRow 5:\nRowRow 6:\nRowRow 7:\nprostate - RowRow 8:\nRowRow 9:\nRowRow 10:\nRowRow 11:\n Row 12:\nto to : Foundation Foundation PALGA- 04:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nreporting reporting (Synoop essential: row row 5: row row 6: row 7: national protocols histology: row 8: Adnexs (row row 9: Rowoxanthoma-Raw 15: Bladder-Urether-Cancer:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nMelanomaRow 2:\nRenal-Pyelum-UretercarcinomaRow 3:\nOphthalmologicRow 4:\nRowRow 5:\nRowRow 6:\n Row 7:\nRowRow 8:\nprostate - RowRow 9:\nRowRow 10:\nRowRow 11:\nRowRow 12:\n Row 13:\nto to paulus:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nptic ptic Reporting) RowRow 5:\nRowRow 6:\n Row 7:\n Row 8:\nnoom)Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 17:\n Row 18:\n Row 21:\nmbiopsy",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5: RowRow 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5: tomatic row 6:Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 24:\n Row 25:\n Row 26:\n Row 27:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\n Row 28:\n Row 29:\n Row 30:\n04:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\nWorking Group Protocols",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nResponsibleRow 3:\nrow 4: Previously assessed: 01-10-2024Row 5:\nLast authorized: 21-09-2018",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 58/428",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nRowRow 4:\n Row 5:\nResponsibleRow 6:\n Row 7:\nRowRow 8:\nRowRow 9:\n Row 10:\nRowRow 11:\n Row 12:\nat at 23-0",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\ninomaRow 2:\ncollen",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: : 01-10-2024Row 5:\nrd: 21-09-2018",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n01-2025",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nde de NVVP/RowRow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\nRowRow 8:",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nening ening (CBURow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\nRowRow 8:",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\noriented. This U) RowRow 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\nRowRow 8:\n Row 9:\n58/428",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: RowRow 3:\n Row 4:\nRrow Rrow 5: Raw 6: longer longer up-2024 2024 ( detection detection (LOD) RowRow 15:\nROW ROW 17:RowRow 18:\n− ROW 19: for for NEGS",
      "start_page": 59,
      "end_page": 59
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: RowRow 13:\n Row 14:\nnot not worked; panel panel and/ techniques techniques ___",
      "start_page": 60,
      "end_page": 60
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: • cancer cancer • ROW 5: • material. material. • Road 6 • 8 8 : analysis analysis (BIA) guideline guideline (see associated products), Raw Raw 17: UndergoingRow 18:\nROW 19: BackgroundROW 20: −Row 21:\nto to 24",
      "start_page": 61,
      "end_page": 61
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nRowRow 4:\nfound found (NGS NGS positive) five five (42%).Row 24:\nLowRow 25:\ńGRADE ROW 26;Row 27:\n~Row 28:\n−Raw 28 Rov-Rov-Now-Raw, −33, RNEX-ROV-Ray, γ - N-Q-R-D-R.",
      "start_page": 62,
      "end_page": 62
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nTuononones, 2013; Xu, 2016). Zugazagoitia (2018) RowRow 7:\n Row 8:\nNGS NGS platforms: RowRow 15:\n Row 16:\nJing Jing (2018), the the Lung'RowRow 20:\n Row 21:\nTuonen Tuonen (2013), NGS NGS (on Illumina platform) RowRow 22:\non on 23-01-2025 63/428Row 23:\n Row 24:\n Row 25:",
      "start_page": 63,
      "end_page": 63
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: RowRow 5:\nRoad 6: 2 2 & 2 (of of __",
      "start_page": 64,
      "end_page": 64
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 4:\n• ROW ROW 5: • ROW 6 • of of • Tested N • PREvalence Sensitvity% false% NGS NGS e* rod 7: 8 8 • rows",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nStudyNGSRow 4:\nrow 5: RowRow 6:\nRoad 7: ~Row 8:\nRowRow 9:\ńRow 10:\n−Row 11:\nSystemRow System",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nuncleRow 2:\n Row 3:\nRowRow 4:\nDNARow 5:\n Row 6:\nRowRow 7:\n~Row 8:\nnranged from <row row 9: −Row 10:\n4Row 11:\n12: ySeq- to to 20-50ng/μLROW 15:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nfReferenRow 4:\ntestRow 5:\nTestRow 6:\n~Row 7:\nROW ROW 8: −Row 9:\n=Row 10:\nRowRow 11:\n-",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nnceTestRaw 4: ROW 5: mutaROW 6:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\ned",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\nationsampl row 2:Row 3:\nrow 4: R38 row 5:Row 6:\nrow row 7: ~Row 8:\nRowRow 9:\n≥99 row 10: R; row row 11:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\nrow 3: PrevalenRow 4:\n Row 5:\nlesmutatio row 6: (using referenc test)Row 7:\n~Row 8:\nin n=RowRow 9:\n−Row 10:\n=8.6%Row 11:\n-Row 12:\n-in n=Row",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\nrow 3: nceSensitiv row 4: ous ceRow 5:\nRowRow 6:\n~(reference reference test)Row 7:\n−Row 8:\n≥100%Row 9:\n-% -Row 10:\n-Row 11:\n=row 12: s100% -",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\nrow 3: vity% false row 4: row row 5: negativeiv row 6: NGS row 7: ~NGS row 8: −Row 9:\n- raw 10: -0% row 11: >row 12: =0% row 13:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\nrow 3: e row 4: row row 5: row row 6: ~ samples row 7: =positive row 8: forRow 9:\n− mutation row 10: •Row 11:\nrow row 12: >(type) *Row 13:\nREZ/3 (EG5=% FR: ORO 27.5: 34%:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: Road 5: arrow 6: • Row@Rout Rout ́ o o ́ ml ml { 0 0 ? ml ml ? Row ́",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nrow 5:Row 6:\ńddPCRRow 7:\n~Row 8:\npossiblePCR possiblePCR (Taqman Row 9): 20 20 ROW",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n_MEDTERM0_ROW 3:Row 4:\nROW 5: ***ROW 6: ~ROW 7: n)_MEPTERM0_CRASE ROW 8: −Row 9:\nROW ROW 10:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nR112n=4Row 3:\nRowRow 4:\n Row 5:\nR101n=34Row 6:\nRowRow 7:\nRowRow 8:\n~n=3 Road 9: −25%Row 10:\ńRow 11:\n=166EGFRow 12:\n≥n=1Row 13:\n1-16%Row 14:\n1row 15: 1, 1,",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n42Row 3:\n5 %Row 4:\n Row 5:\n48Row 6:\n5%Row 7:\nAS:Row 8:\n302,Row 9:\n%Row 10:\n Row 11:\nFR:Row 12:\n190Row 13:\n% Road 14:Row 15:\nRowRow 16:\n% ROW 17:Row 18:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n95.2%Row 3:\n Row 4:\nrow 5: 96%Row 6:\n~Row 7:\n1 00% Road 8:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n4.8%16/70=23Row 3:\n Row 4:\n4%1/53=2%Row 5:\n Row 6:\n-0%KRA KRA mut% S (RowRow 7:\n~",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: ROW 6: lung lung carcinoma0=RowRow 7:\ntime time PCR; Threascreen / AmoyDx_MEDTERM1_, KRAS, __",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nspecificity; RowRow 2:\n Row 3:\nRowRow 4:\nof of 100% than than 100% (Gao, 2016; toegenomen, 2018; of of Rod(s) spasms. spasms.",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nsamplesRow 2:\n(both)",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "ROW 1: ROW ROW 2: time time PCR; Threascreen / AmoyDx_MEDTERM1_, KRAS, _",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nFR 3% AS 96% not not cultured)_",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nrow 3: axis axis 6; Jing, 2018; ged from 4% to 16%.Row 4:\nrow 5:Row 6:\nED testing% failed tests (PCR)Row 7:\n~",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: Road 5: Raw Raw 6: RRAS, EGFRBAR_RAD: 20%-ROW 7: 2. NGS-IonT_MENTERM1: 16%Row 8:\n~ ROW 9: ́R% 10: C-112 C-112 Red(C)",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row_ 1: RowRow 2:\nRowRow 3:\n2. NGS- IonTRow 4:\n Row 5:\nngddPCR ngddPCR /Row 6:\nSangerRow 7:\ńRow 8:\npossiblePCR possiblePCR (Tawl)(Row-Iow,",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nCRAS __MEDTERM1_ROW 3: row 4: row 5: _MEDTERM1_ Road 6: ~ row 7: {Row 8:\nman}row row 9: }Row 10:\n\\row 11: a_",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nrow 5: R112 row 6: ROW 7: row row 8: ~Row 9:\n−Row 10:\nrow row 11: -Row 12:\nR-109 row 13: ●Row 14:\n1row 15: ontraindications -",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nCRAS: 20%Row 3:\n___MEDTERM0_: 16%Row 4:\n Row 5:\n17/129=1Row 6:\n~Row 7:\n95.5%Row 8:\n−",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n% -Row 3:\n%Row 4:\nrow 5: 13%-Row 6:\nRoad 7: ~_",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: Road 5: lung lung carcinoma' ROW 6: tests tests (D'Haene, 2015; Legras, 2018; Tuononen, 2013). RowRow 17:\n Row 18:\nand and (RowRow 28:\n Row 27:\nlimited limited (",
      "start_page": 69,
      "end_page": 69
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nROW 3: = ROW 4: RowRow 5:\nlimitations limitations (risk of bias) and imprecision (samples samples tested). # Row_raw 7: equals equals 9; row 8: excluded excluded (tab tab Methods), RowRow 22:\n Row 23:\nResultsrow 24: Row",
      "start_page": 70,
      "end_page": 70
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n1 - of of __",
      "start_page": 70,
      "end_page": 70
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nOne. One. 2015;10(9):e0138245. doi: 10.1371/RowRow 6:\n3",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 71/428",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW Mechanisms 1: ROW ROW 2: RowRow 3:\nRaw 4: RowRow 5:\nRoad 6: with with ~_MEDTM1Roved therapyRaw 7: RecommendationRow 9:\ńROW 10: the the {ME Box]S- treatment treatment (for example;_ gewetenterm1_# RometerM0_; transformation transformation (Oxnard Oxnard 2018))) as as /_MEPTER_10_, will be",
      "start_page": 72,
      "end_page": 72
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: RowRow 5:\nanalyses analyses (mutation mutation analysis). Road 6: Cost (means deposit) Raw 8: provide provide 24-( thus) and and 25-( previously) with with row-T",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\n• ROW ROW 5: • therapy therapy (included included (Oxnard, 2011; Ji, 2013; Matsuo, 2016).'Row 28:\n Row 29:\nMok (2017) trial trial (AURA3) with with T790M- after after first-line",
      "start_page": 74,
      "end_page": 74
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\ncRow 3:\n Row 4:\nROW ROW 5: survival survival : 0.53 (95% P P = 0.002). Nie Nie (2018) __MEDTERM0_ __MEDTERM0_ (___medterM0; ); as as Rower's partner.",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: O:RowRow 6:\nrow 7: measures-Row measures-Row 8:\n2 2 (equal. equal.",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 76/428",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: RowRow 3:\n Row 4:\nRowRow 5:\nRoad 6: adequate adequate staging? Rrow 7:commenceRow 9:\n# Raw 10: detect detect (micro)_MED®Wow Wow 11: studies studies (and and melanoma) RowRow 20:\npatients patients (their their carers) ROW 21: Raw Raw 22: Row Row 25",
      "start_page": 77,
      "end_page": 77
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nSubstantiedRow 4:\nROW 5: Background Rrow 6: Road 7: pre-operative pre-operative and/ disease disease (Rovange'the the EU/ EB_ Selective/ patients patients (Dai, 2013; Dobashi, 1997; Goldstein, 2000; Gu, 2002; Izbicki, 1996; Li, 2008; Martin, 2016; Nosotti, 2005; Rena, 2007; Rosch, 2011; Wu, 2001; Yamashita, 2010; Yasumoto, 2003.) hospital. hospital.",
      "start_page": 78,
      "end_page": 78
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: Dai (2017) adenocarcinoma adenocarcinoma (stage I). cytokeratin cytokeratin (AE1/AE3) and aspartate-lactate- Jeong (2018) 25. 25.3% (95%CI 20-320%); 23. 23.1% (95% CI 18-29%). 33. 33.7% (95% CI 26-43%). rates rates (Dai, 2017: 15%; Gwozdz, 2018: 9.5%; Ren, 2018 : o. o. • Roryvre • rossie • r",
      "start_page": 79,
      "end_page": 79
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: • ROW ROW 5: Road 6: ́Row 7:\nMartin (22) were were made: other. other.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nROW ROW 5: respectable respectable __MEDTERM0_?Row 6:\n Row 7:\nP:patients with resectable___MENTERM0_;Row 8:\nI:tables. tables.'Row 20:\n Row 21:\nResponsibleRow 22:\n~Row 23:\nLast assessed: 07/07-220 row 24: Last authorized 07-07-202",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 81/428",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n2018 Feb;214(2):240-244. doi: 10,1016/RowRow 6:\n4",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 82/428",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n2018 Feb;214(2):240-244. doi: 10,1016/RowRow 4:\n4",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n.Row 4:\nRowRow 5:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n2018 2018 Dec;25(Row 5:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nicrome (13):38 row 5:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n82/428",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: lung lung - Rrow Rrow 3:Row 4:\nis is 'chromosome chromosome 5: be be addressed: _MEDTERM1 _MEDTERM1 : question question (see Attachment):",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 83/428",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRaw Raw 2: cancer cancer - RowRow 3:\nRrow-RD 4: row row 5: be be addressed: 0 0 : question question (see attachment): that that the",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\nRowRow 14:\n Row 15:\nrow row 16:Row 17:\n Row 18:\n Row 19:\n Row 20:\nRowRow 21:",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\nrow 2: LCrow 3:Row 4:\nes.Raw 5:Row 6:\n~Row 7:\n{Row 8:\nectable__MEDTERM1_?Ray 9: =Row 10:\n}Row 11:\nedction/biopsy ten#Row 12:\n−Row 13:\nLC? ROW 14:",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\ndone done (1) (3) (4). by by ≥ 1/ 2 Rodialysis",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 84/428",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Thoracoscopic surgeryRow 3:\nRov Rov 4: Baseline questionRaw 5:Row 6:\nresectable resectable __MEDTERM6_?Row 7:\ńRow 8:\nRecommendationROW 9: ~ROW 10: patients patients ~RowTerM1 RewTer'thoracotomy thoracotomy (2).Row 26:\n Row 27:\nResponsibleRow 28:\n-Row 29:\nLast assessed 22-05-2011Row 30:\nLast authorized: 22/05-2011",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 85/428Row 2:",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nRowRow 6:\n2",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nCardiovasc Surg ;139:976-983Row 2:\n Row 3:\non on 23-01-2025 86/428",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nRowRow 6:\n2",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nCardiovasc Surg ;139:976-983Row 2:\n Row 3:\non on 23-01-2025",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nlung lung cancer: RowRow 6:\n Row 7:\n86/428",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nRrow 4: of of Ro",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\ndissection dissection (baseline baseline question: site site of",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\na resection? staging staging - sampling sampling dissection/resection. resection.",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 87/428",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "RowRow 16:\nsleev sleev -compared compared to",
      "start_page": 88,
      "end_page": 88
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nROW ROW 3: 1. T1-the the operator'the the surgeon'large large and/or circumfer",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nWarren 1994, (5) Martini1994, (60) Landreneau 1997. (7) a a T1N0- or T2N0-0- Level Level 2: Erret 1985, (2) Level Level 3: 1991, (36) Shah 1994, (38) Pitz 1996, (64) Downney 1999, (39) Elia 2001, (41) Magdeleinat 2001. (40) Level Level 3: Weksler 1997, (43) Rocco 1999, (44) Riquet 2000, (45) Fujino 2000, (46) Burt 1987. (47) a a tracheal",
      "start_page": 90,
      "end_page": 90
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nLevel Level 3: 2001. 2001. (58)Row 6:\nRowRow 7:\n Row 8:\nRowRow 9:\n Row 10:\nT1-T2 tumors",
      "start_page": 91,
      "end_page": 91
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 91/428Row 2:",
      "start_page": 91,
      "end_page": 91
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nROW ROW 5: common common one-to-the the lung'intestinal intestinal tumor(s) (i.e., pneumo-bodied pneumo-bodied intestine), ventriculectomy ventriculectomy (in the absence/electomy) series, 5-8% a a sleeve- lobectomy (31). the the RA/ the the sle",
      "start_page": 92,
      "end_page": 92
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nrow 2: row 3: row 4: row 4: Raw Raw 5: 13 13 benodigde/ 3636 3636 l",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-20254/808Row 2:",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "rgebied rgebied r",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nence'Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\nmelen melen 38) d), g of ) ve",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1:Row 2:\n Row 3:\n Row 4:\n Row 5:\nROW ROW 6: T4 tumors; is is rare: patients patients (43). is is limited: is is 20%. Resection and block' survival survival (53) (54). done done _",
      "start_page": 94,
      "end_page": 94
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: • ROW ROW 5: • invades invades • hospital hospital (in%) • survival survival (in %, maximum titres) Row 6 • Row 7 • 0 0 23} Row 8 • 26 26 (13-42) Row 9 • Left ventricular(5 85 -resection resection •",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n1 - Surg Surg 60:RowRow 6:\nRow 23-20: PDF:",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nCardiothorac Surg 15:426-432,Row 2:\n2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 96/428",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 96",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\ngrandma row 4: -10, row 5: row 6: orac row 7: sc",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nary row 2: for row 3: ung row 4: mall row 5: row 6: 5:10 row 7: row 8: row row 9: rg",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nd J",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nrow row 2: row 3: orc",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nrsRow 2:\ncellRow 3:\nOMY row 4:Row 5:\n/428",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n2",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n38 - cancer. cancer. 'Thorax 50:782-784', 1995.Row 2:\n3",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n4Row 2:\nSurg Surg 114:500-501Row 3:\n4",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n4Row 2:\nSurg Surg 48:130-133Row 3:\n4",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n5'0 - Surg Surg 60:1854-51995.Row 2:\n Row 3:\non on 23-01-2025 97/428",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: RowRow 4:\n51 - Surg Surg 102:RowRow 5:\n5",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n59 - carcinoma. carcinoma. 'Surg Surg 8:475-483,'1979.Row 2:\n6",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 98/428",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "RowRow 2:\nGoldstraw Goldstraw (data data transl). are are distinguished: life life (4. 4.4). of of the",
      "start_page": 99,
      "end_page": 99
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nperformed performed (4) (9) (10) (12) (15) (5). (R0: resection resection planes; R1: left left over; R2: tissue tissue remained) Rrow 4: ROW 5: excluded excluded (Row s disease- RowRow 10:\n Row 11:\n1Row 12:\nRowRow 13:\non on 23-01-2025 100/on on 23-01-2025 100)/428",
      "start_page": 100,
      "end_page": 100
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2: RowRow 3:\ndefertially-confirmed defertially-confirmed data- In approximately 30% N1 N1 nodes; the the R1+no no 4+ Roentinel-Laxation Roentinel-Laxation (cytokeratology cytokeratology (31) (34) (41) (43). Sentinel-lymphompeia--standardized standardized (44) (45). In",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRaw Raw 3: rum-by-paw,rst-to-round and run- through- the-side-of-all-body test. Row-After-Hors-To-Don't-Come-Once-in-a-reaction test Roughness-Against-Everybody-Valve-Me,-From-Yourself-Bovest-",
      "start_page": 102,
      "end_page": 102
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nROW ROW 3: 244 244 **lymphadenopathy lymphadenopathy Lung: whole. whole.",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nUnderRow 2:\nsearch type",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nretrospective retrospective P= to to (almost) NVRV NVRV Tel: +49 728.",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nauthor;Row 2:\nyear of",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nrow 2: 0. 0.7%; RowRow 3:\nradiateral radiateral radioisolaterally: e. e. • locus cervix • node node • row 4 * cholecystoms cholecystoms • local anaesthetic • hematocrit hematocrit • system system • renal function",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nositive: 0%; gaïve: twaalf ng: 0.6%Row 3:\nossitive: 205; gative: row 4: row 5: copical ng + hilar row 6: row 7: ns row 8: ~ row 9: − row 10: row row 11: ctievel row 12: ndelaar row 13: row row 14: divider are 20: row 15:",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Roow 1:Row 2:\nROW ROW 3: • Okumura 1991 (46) Ice-Comparator Ice-Comparator lCE-stage stage ́ to to Ro",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nOkumura 1991 (46)Non-vergeliRow 3:\n Row 4:\nKondo 1993 (47)Not-vergeliRow 5:\n Row 6:\nBuhr 1997 (48)non-vergeliRow 7:\n−Row 8:\nHillerdal 1998 (51) Non-vergetiRow 9:\n=Row 10:\nDresler 1999 (49)Row",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\ninomaRow 2:\ncalibratingRow 3:\n Row 4:\ncalibrating row 5:Row 6:\nkalating row 7:Row 8:\nkalifying row 9:Row 10:\nkalificing row 11:Row 12:\n Row 13:\n01-2025",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4:Row 5:\n Row 6:\nRowRow 7:\n~Row 8:\nrow 9: −Row 10:\nd'12. 12.3*",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\nrecurrence recurrence (pleura/ pericardium) than /+ rash rash (0. 0.7%; p < 0.05)correlated correlated ≥ 1/ 2. 2.1% 3. 3.9% negative negative ≥ 1/ 10 mg",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\ncancerarrow cancerarrow 3: Okada 2003 (54)after after thoracotomy; Papanicolaou Papanicolaou staining; results results 28% results results 62% (p < 0.0001)factor factor (p = 0.029); 2 2 Raw: Row",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\ndatabase. database. ́Row 2:\n Row 3:\nreferringRow 4:\nrow 5: 1 - Surg Surg 72:Surg Surg 23:229-232, 2003.'Row 13:\n9 - Surg Surg 16:RowRow 14:\n10 - Hawald Sr.",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n1",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n464Row 2:\n1",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n2Row 2:\nPathol Pathol 13:237-243Row 3:\n2",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n29 - Bronchialkarzinoms. Bronchialkarzinoms. Stuttgart: RowRow 2:\n3",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n35 - cancer. cancer. 'Chest 123:RowRow 2:\n36 - a a difference? 'Lung Cancer 2002;36:RowRow 3:\n3",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 106/428",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nSurg Surg 126:RowRow 6:\n3",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n41 - Am Am 67:RowRow 2:\n4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n45 - Am Am 82:RowRow 2:\n4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n113:683-690Row 2:\n4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 107/428",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nSurg Surg 126:RowRow 4:\n3",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 10",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nntRow 5:\nEur J",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nctionRow 2:\n Row 3:\ner:Row 4:\ndRow 5:\non-Row 6:\n Row 7:\ncerRow 8:\ngyRow 9:\n Row 10:\nn",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n07/428",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Lymph node amputation/mediastinal dissection/ RowRow 3:\nRough Rough 6: mastectomy mastectomy / mediastinal dissection / a a resection? RowRow 7:\nRecommendRow 9:\n17 17 : status status (N2 stations) right right lobe",
      "start_page": 108,
      "end_page": 108
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nROW ROW 5: Level Level 2: 1968, (7) Holaday 1974, (8) Kaufman 1986, (9) Oneson 1989, (10) Mair 1991, (11) 1993, (13) 2004. 2004. (15) and and distance-of-the-left lung (Bronch (36) is is similar;Level Level 1: B Allen 2006; (6) 2005. 2005. (1) Level Level 2: B Allan. (6) higher higher Roamp:",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nROW ROW 2: Level Level 2: 1968, (7) Holaday 1974, (8) Kaufman 1986, (9) Oneson 1989, (10) Mair 1991, (1 1993, (12) Nashef 1993, (13) 2004. 2004. (15) level level 2: 1992, (16) Hermaneklekleknekneum (n = Level 1: B Allen 2006; (6) 2005. 2005. (1) Level Level 2:B Allen. (6) Level Level 1: 2005. 2005. (1)Row 3:\nRowRow 4:\n Row 5:\non on 23-01-2025",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n(11) and and 002; (20) RowRow 3:\n Row 4:\n109/428",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRaw 2: ROW ROW 3:Row 4:\nRowRow 5:\npatients patients (2) (3) lymph lymph node(s) outcomes outcomes (1). randomized randomized studies; IASLC IASLC (Rami Porta) Surgery Surgery (ESTS) statement statement on",
      "start_page": 110,
      "end_page": 110
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: arrow 5: row row 6: of of __MEDTERM0_s",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n227:138-144Row 2:\n3",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1Row 2:\nPathol Pathol 13:237-243Row 3:\n1",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 111/428",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: thorax thorax 48:RowRow 6:\n1",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n17 - tumor tumor (R) prognosis. prognosis. 'Oncol Oncol 10:12-20', 1994.Row 2:\n1",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n464Row 2:\n2",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n559Row 2:\n2",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n31 - Bronchialkarzinoms. Bronchialkarzinoms. Stuttgart: RowRow 2:\n3",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 112/428",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\nRow 4 : member member ROW-procedure procedure report; the the operation? ROW-12:Row 8:\nsection section examination: R0: resection resection planes; R1: tissue tissue left; R2: noteworthy. noteworthy.'Row 34:\n Row 35:\nAnsweringRow 36:\n-Row 37:\n- row 38: on on 11-01-2025:",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nLast assessment: 22-05-2011Row 4:\nLast cleared",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 114/428",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nLately assessed: 22-05-2Row 4:\nLast authorized: 2/2/2 row 5: row 6: RowRow 7:\n?Row 8:\non on 23-01-2025",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n2011Row 4:\n2011",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nRowRow 2:\nrow 3:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Start page - lung lung carcinoma (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading Startpage - lung lung carcinoma (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow 4: row 5: row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n114/428",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: survival survival is: this this study: RowRow 26:\n Row 27:\nsub-lobar sub-lobar (segment) RowRow 28:\n−Row 29:\npatients patients (their their caregivers) Road 30: trials trials with",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: Costs (cache of means) row 5: available. available.\" row 6: arrow 7: row row 8: ROW ROW 12:Row 13:\nRationale/ RowRow 14:\nRaw Raw 16: I I ~ ROBST",
      "start_page": 116,
      "end_page": 116
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: • cancer cancer • Row 5 • I I •wice weekly • Row territory • Road Road 6: arrow 7: Conclusions Raw 8: ~ ROW 9: °T (0) patients patients (n=58 patients) enrolment enrolment (anticipated entolment: ROSEL ROSEL trial). of of Glipsid's velocities.",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: lung lung carcinoma'Row 6:\nChen Chen (2018). we we didn'cohort cohort (N=5x12 5x12 Gy; N=15: 3x20 Gy; R=4: 33x18 Gy; 8x7.5 Gy). lobectomy lobectomy (n=londectomy, n=lumpectomy, N=surgery surgery (or or pneumonectomy). patients patients (27,200 patients), 0. 0.79% RowRow 19:\non on 23-01-2025 118/428Row 20:",
      "start_page": 118,
      "end_page": 118
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: RowRow 6:\n2. 2.41% patients patients (difference 1.62%; P<.001). 2. 2.82% 23 23 % treated treated patients(difference 1.41%; P=0.001). for for 90- 66 66 (95%N-α. N-α.",
      "start_page": 119,
      "end_page": 119
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nstudiesRow 3:\nrow 4: Road 5: lung lung carcinoma' ROW 6: (Absolute risk reduction: 35%, 95% CI: (13% to 56%); NNH: death. death. ~Row 7:\n2. 2.7% (11/405).Row 15:\nRov 16: Versteen",
      "start_page": 120,
      "end_page": 120
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: lungrow lungrow 5: 026 026 (95%: 0. 0.080) groups groups (Wolff 2018). difference difference (MID) groups groups (2 2 cm) design design (Risk of bias), heterogeneity. heterogeneity. #Row 11:\nrate rate 12: following following criteria: or or cohort'Row 36:\non on 23-01-2025 121/428'",
      "start_page": 121,
      "end_page": 121
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: RowRow 6:\nexcluded excluded (spontaneous spontaneous contraception) Rod:",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 122/428",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - (Neo)resectable resectable __",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nAt pN0-1- ROW ROW 3:Row 4:\nfor for pre- or postsurgical radiotherapy? (consensus based 2013) ROW 5: therapy therapy ~ALONG ALONG Criteria:",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 123/428Row 2:",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: RowRow 5:\narms arms (1) (2). diagnostic diagnostic T___MEDERM0(S)radiotherapy radiotherapy ('split course' 20 20 Gy) chemotherapy chemotherapy (CAP) (7).control. control.' ROW 6: ROW 7: consensus consensus based(2013) ROW 8: Patient ́to to CEFTA",
      "start_page": 124,
      "end_page": 124
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n703660",
      "start_page": 124,
      "end_page": 124
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: Road 6: group group (76 76 (95 % 61-0. 61-0.95), p=0.02). reduced reduced (31 31 - 5% 79, p=0.012] later later time",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\nrow 5: 1- carcinoma. carcinoma. 'Cancer 30:1388-1394', 1972.Row 6:\n2",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 125/428",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(Neo)I-III I-III _",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\n(Neo)RowRow 3:\n Row 4:\nsub sub modules:Row 5:\n7 7 (NEO)Road Road 10: on on 23-01-2025",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nLC row 3:Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow 5:Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n126/428",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nROW ROW 2: carcinoma carcinoma - IIIA_MEDTERM7_Raw IIIA_MEDTERM7_Raw 3: the the 45-year-olds' questionROW questionROW 5:Row 6:\nIA IA -IIIA [MEDTERM7_?Row 7:\nROW 8: years years (91, 95% 81-1. 81-1.02; P=0.10)Row 17:\n Row 18:\nUndergoingRow 19:\ńRow 20:\nConclusionsRow 21:\n~Row 22:\nLevel Level 1: 2003 2003 (2), Waller 2004 (3) International Adjuvant 1995",
      "start_page": 127,
      "end_page": 127
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 127/428",
      "start_page": 127,
      "end_page": 127
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n2005 2005 53-74% II II 25-46% cm cm (T2a T2a (3-5 cm) T2b T2b (5-7 cm) a a __MENTERM0_Adjuvant: For patients ___METM0_",
      "start_page": 128,
      "end_page": 128
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: RowRow 5:\nbenefit benefit (86, 95% 92, p<0.0001), of of 4% (95% CI 3-6%) years years (from 60% to 64%). The second __MDTERM",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 129/428",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\n[ANITA]): trial. trial. '7. 7.719-727', 2006.Row 6:\n7",
      "start_page": 130,
      "end_page": 130
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 130/428",
      "start_page": 130,
      "end_page": 130
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(Neo)RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\ncarcinoma carcinoma ?? baseline baseline ́ RovMED's ** ROW 17: *(impairment impairment (4. 4.4), are are resolved",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: therapy therapy (perioperative treatment) Raw 5: regimen regimen (RowRow 16:\n Row 17:\nROW ROW 18: the the ROWED-Ad(s)-diagnosed-the the Rowed-To-Dose ́the the excipients",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: lung lung carcinoma' ROW 5: the the risk-Mad(s) of the patient's benefit-Md(s). the the risk/and and __MDTM4_- least least 50% on on PD- RowRow 12:\nRov 13: ___ ___ M___",
      "start_page": 133,
      "end_page": 133
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: ROW ROW 5: _MEDTERM0_ + placebo placebo + randomized randomized 1:the the _MEDERM0*- 9 9 : From the patient'12 12 : a a potentially",
      "start_page": 134,
      "end_page": 134
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: ROW ROW 5: from from $46.859/ QALY. Das (2023) of of $150,000/ of of $46.859/RowRow 13:\nRaw 14: Conclusions ROW 15: ́ Rrow 16: RowRow 17:\n~ Rov Rov 18:Row 19:\nr. r. o",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Veronica:Row 1:\nraw 2: row 3:Row 4:\n• ROW ROW 5: RowRow 6:\n−Row 7:\n~Row 8:\n=Low",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nrow row 2: GRADE",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: alone. alone. #Row 6:\ń",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ntrial trial (Forde 2022) __MEDTERM3_ __MEDTERM3_ (IB (≥4 cm) to IIIA __ELDERM3_) (7th TNM classification) known known __EDTERM1_/__MDTERM0_ __MDTERM0_ (360 mg) Rodapy Rodapy (threat):",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: • cancer cancer •Row 5:\n• randomized randomized (study study arm) months months (5 5 months). noted noted (Tel. Tel.: +49 (0)1 7, Ro",
      "start_page": 138,
      "end_page": 138
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n* RowRow 2:\n Row 3:\nResults row 4: RowRow 5:\nthe the __MEDTERM0_-group. group. (82. 82.7% _MEDTM0_ _MEDTM0_ -plus- together-group together-group (",
      "start_page": 138,
      "end_page": 138
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Raw Raw 6: was was 41% (72/179) in the __MEDTERM0_+ versus versus 44% (77/179) group group (Forde 2022).'Row 7:\nRoad 8: bias bias (in in RoB).'Row 18:\nlow. low.'Row 19:\n Row 20:\nexecution execution (one one level) equal. equal.",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: immunotherapy immunotherapy (perioperative treatment) Road 7: Description of trials' ROW 8: trial trial (Wakelee 2023) IIIB IIIB (N2 stage) __",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nimmunotherapy (perioperative treatment)Row 2:\n Row 3:\non on 23-01-2025 140/428Row 4:",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW 3: Row Raw 4: RowRow 5:\nTrialStudyControOutcomesRow 6:\n(authordesignRov(Rov) + Rov-80. 80.9% (95% CI: 76.2-84.7) the the __MEDTERM0_+ 77. 77.6% (95% CI; 72.5-81.9) RowRow 34:\n Row 35:\n85. 85.0% (95% 9-95. 9-95.2) ___benzeterM2_ ___benzeterM2_ + chemotherapy 41 RT: Rofill: rofill:",
      "start_page": 141,
      "end_page": 141
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: the the __MEDTERM0_-plus- months months (95% CI: 14.3-22.0) group. group. (HR: 0.58; 95% CI: 0.46-0.72; p<group group (30.2%; 95% CI: 25.7-35.0) group group (11.0%; 95%CI: 8.1-14.5) (Wakelee 2023).' ROW 12: ROW 13: received received __",
      "start_page": 142,
      "end_page": 142
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: RowRow 5:\nlevel level (imprecision, one level) bias bias (one level). Road 6: analysis analysis (Felip, 2021) 2 2 (27.5-38.4) analysis analysis , The voornamelijkce, 2023) months months (5-52. 5-52.3).'Row 19:\ndeath. death.",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Rowbas 1:Row 2:\nrow 3:Row 4:\n• 5 5 •Row 6:\n• life life (Table 6). • Row 7 • Table 6 • Raw Raw 9: Trial; author, yearStudy • Row",
      "start_page": 144,
      "end_page": 144
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: Results'Row 2:\nOverall survival'Row 3:\nmodule module (May 2023) Felip Felip (2021) with with 97/507 (19%) __MEDTERM0_group __MEDTERM0_group and",
      "start_page": 144,
      "end_page": 144
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: lungrow lungrow 5: Road 6: eventrow eventrow 7: _medeterM0_, 22% (108/495) to to 12% (57/495) group group (Felip 2021). The __MEDTERM0(226 226 (39%) 84 84 (37%) steroids steroids (Gangulu Gangulu 2022). #Row 10:\nthatRow 11:\nRowRow 12:\nstudies. studies.'Row 13:\nROW 14: equal. equal.",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\ncancer cancer (__MEDTERM0_)?Row 2:\n Row 3:\non on 23-01-2025 145/428",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nrow 6: P:early-stage early-stage (to to IIIA) pathologically confirmed __MEDTERM0_;Row 7:\nI:adjuvant adjuvant (or both) other other treatment;Row 8:\nC:treat treat 9:",
      "start_page": 146,
      "end_page": 146
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\noutcome outcome measure- where where disease/eligible eligible (IMpower010, PEARLS/KEYNOTE-091).' ROW 14:Row 15:\nand and Ovid/Medline. The querymentsheimer'ground. ground.",
      "start_page": 146,
      "end_page": 146
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: row 5: ROW ROW 6: RowRow 7:\nResultsRow 8:\nthe the literature: chemoimmunotherapy chemoimmunotherapy (Table 1), death. death.",
      "start_page": 147,
      "end_page": 147
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Trial (author year) STAGE STAGE (N) 7 7 WT(R-III) RockMate 816 (Felip Felip 2022)RCT (phase III)Neoadjuvant__",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nimmunotherapy (perioperative treatment)Row 2:\n Row 3:\non on 23-01-2025 148/428",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nTrial (author year)StudyInterventionControRow 3:\n816 816 (Felip Felip 2022)RCT (phase III)Neoadjuvant __",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nol row 3: row 4: chemothe chemothe cycles) row 5: juvant nab- xel + platinum row 6: juvant __MEDTERM0_ (1500' row 7: row 8: ~ row 9: jaw mab' row 10: { row 11: row row 12:",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\nrow 2: Stage (N)TNMRow 3:\n Row 4:\ninum-erapyIB or II: 1277Row 5:\nROW 6 IIIA: 228row 7: - numIII A: 668 row 8: ~IIIB: 22row 9: 0 mgIA3: 127 row 10: − 14IIA: 10row 12: row/II:",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 3)",
      "text": "Row 1:\n Row 2:\n148/428",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: ROW ROW 5: RowRow 6:\n(authordesign(N)Row 7 : mg mg ́Red(4-M)Radio-DemandRadiosyn.",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nStudyInterventionControlStageTNMRow 2:\ndesign(N)Row 3:\nPEARLS / KEYNOT-9091 (OBrien 2022)RCT (phase III)Adjuvant __MEDTERM0_(18 18 cycles) + adjuvant chemotherapyPlateletPlaceboIB: 1697Row 4:\n(18 18 cycle(202) as as Rowd-III: row-III Red",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 1)",
      "text": "Row 1:\nRowRow 2:\nTrialStudyInterventionControlRow 3:\n(authordesignRovertRaw 4Row-Raw 5KEYNOTE- 671 (Wakelee 2023RCT (phase III)NeoadjuvantNEOadjuvant placebo (4 cycles)RiveterM0_ RiveterM0_ (200 mg) +(",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\n Row 2:\nStageTNMRow 3:\n(N)Row 4:\n Row 5:\noII: 2398Row 6:\nIIIA: 442Row 7:\n~IIIB: 116Row 8:\n−Row 9:\nxelT1N2M0: 168 row 10: ≥",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (column column 2)",
      "text": "Row 1:\nStageTNMRow 2:\n(N)Raw 3: IB: 1697Row 4:\nantRow 5:\nII: 667ROW 6: ~IIIA: 339Row 7:\n−VI: 2Rrow 8: row row 9: {row 10: }IIA: 295ROW 11:",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: Last assessment: 01-01-2023 row 5: Last approved : 24-06-2024",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 150/428",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n2023 2023 Oct;34(10):907-919. doi: 10,1016/17. 17. PMID: 37467930.Row 6:\n1",
      "start_page": 151,
      "end_page": 151
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 151/428",
      "start_page": 151,
      "end_page": 151
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nROW ROW 5: Raw 6: cancer cancer (stage I-III) for for ?IMD(A) or not? the the MAH'survival survival (EFS) versus versus 80% risk risk of",
      "start_page": 152,
      "end_page": 152
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1:Row 2:\nRoad 3: row 4: • ROW ROW 5: this this benefit/ risk/ Roally Roally ́s",
      "start_page": 153,
      "end_page": 153
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: carcinoma carcinoma (stage I-III), current current (anno 2023) adjuvant adjuvant chemotherapy; RowRow 5:\nROW 6: ConclusionsRow 7:\ńRow 8:\nAdjuvant __MEDTERM0_* early-stage early-stage (IB' ROW 9: to IIIA) pathologically confirmed;__METERM7_+___#",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 154/428Row 2:\n Row 3:",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n__EDTERM4_ __EDTERM4_ (7th TNM classification). receive_or_MDTERM0_ receive_or_MDTERM0_ (n=63) (times times daily) undergo_observation undergo_observation (fatigue vs.",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nHe (2021) - EvidENCE",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nWu (2020) / Majem (2022) / Herbst (2023) / Tsuboi (2023), / John (2023 ) - ADAUR",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nZhong (2018/2021) - ADJUVANT",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 155/428'thRow 2:\n Row 3:\nrow 4:",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: ROW ROW 6: __MEDTERM0_ versus cis/II-IIIA II-IIIA (7th TNM classification) {",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nKelly (2015) RADIANT",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nFeng (2015)",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nLi",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 156/428Row 2:\n Row 3:",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: __MEDTERM0_ __MEDTERM0_ (n=30) chemotherapy chemotherapy (500 mg/and and carpoplatin), group group + __MEDTERM15_. __MEDTERM15_.' ROW 14: RowRow 15:\nlife_Row life_Row 17:\nT. T.",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: was was 89% (95% CI 85% to 92%) with with 52% (95% CI 46% against 92%) 20 20 (99.12% 0. 0.30). interval interval == consciousness average -> 50% -00% -0.1% -0.6% -0 % -0.9% - 7 7 (95% to to 12) RowRow 12:\n Row 13:\nin in 54/339 patients (16%) (95% CI, 12% to 20%) ___ ___ 39% five five (1%) the the __",
      "start_page": 158,
      "end_page": 158
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nRoad 5: lung lung carcinoma' ROW 6: to to follow-up) and imprecision (e. e.? low. low.'Row 7:\n Row 8:\nlow. low.'Row 13:\n Row 14:\nRowRow 15:\n~Row 16:\nRoad Road 17: following following question:'Row 18:\nearly-stage early-stage (Testage I-III) lung cancer:",
      "start_page": 159,
      "end_page": 159
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nI:gewetenM1_, •RoventerM2_, +RovderM2+, +BraderM3_, BRAF, _IMEDTERM4_alterations;Row 2:\nC:chemotherapy or placebo;Row 3:\nO:RowRow 4:\nRovender's disease forerunner:",
      "start_page": 159,
      "end_page": 159
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: lung lung carcinoma'Row 5:\n• Toxicity (grade grade ≥3): groups. groups. ~Row 6:\ńRow 7:\nselect select (Methods)Row 8:\nZhao Zhao (2022) Zhao Zhao (2022). found found (Majem, 2022). mutation. mutation.'Row 14:\n Row 15:\nRCTs RCTs and&database. database.",
      "start_page": 160,
      "end_page": 160
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 160/428",
      "start_page": 160,
      "end_page": 160
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nRowRow 5:\n Row 6:\nReferencesRow 7:\n Row 8:\n1",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 161/428",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n1",
      "start_page": 162,
      "end_page": 162
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 162/428",
      "start_page": 162,
      "end_page": 162
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - row row 3:Row 4:\nis is 'stage III_MEDTERM4_' RowRow 5:\nrow 6: these these (sub) Wow Wow 8: stage stage III-/MEDTERN4_ ~ WERE WERE DISCUSSED",
      "start_page": 163,
      "end_page": 163
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 163/228",
      "start_page": 163,
      "end_page": 163
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nrow row 5: row 6: patients patients __",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "ROW 1: NSCLC?Row 2:\nROW ROW 3:Row 4:\nUndergoingRow 5:\n Row 6:\nConclusionsRow 7:\n Row 8:\nand and WHO-performance'-2 2 Gy/prolonged prolonged loco",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 164/428",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nrate rate (65%) radiotherapy radiotherapy (tumor tumor control) pragmatic pragmatic concerns: IMRT IMRT (Intensity Modulated Radiotherapy) regimen regimen (RowRow 6:\non on 23-01-2025 165/428",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n108-59710776148514281",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n490-5383261",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n165126",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: of of chemotherapies- of of 23% versus 11% (p = 0.0066) CERETM0_s CERETM0_s 49% at distance (70%",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n1283",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n398-444357",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n491'89",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n496.53457755",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n282-28394",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: Lately authorised: 17-10-2014",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nOncol 8:543-555Row 2:\n6",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nPhys Phys 27:507-516Row 2:\n8",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nChest 117:358-364Row 2:\n1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nRadiother Oncol 52:129-136Row 2:\n1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n165Row 2:\n1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\non on 23-01-2025 167/428Row 2:",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n(dose/volume) lung lung cancer: Cancer Cancer 41:RowRow 6:\nCancer 41*207-214Row 7:\n1",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n20;28(36):5301-10.Row 2:\n1",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nChest 117:358-364Row 2:\n2",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\nOncol 15(Suppl 7):20-25Row 2:\n3",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 168/428",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: Phys Phys 20131;85(2):444-50. [link]Row 6:\n3",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n5'0 - Oncol. Oncol. 2010;20(2):94-106. [link]Row 2:\n5",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 169/428",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n2003.Row 6:\n6",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 170/428",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "carcinoma carcinoma - the the Roval-Meadwell-Radio-of of Row-10. 10.7%;68 68 (95% 0. 0.85). unknown unknown PD- RowRow 26:\n Row 27:\n265 265 (",
      "start_page": 171,
      "end_page": 171
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: placebo placebo (1 mg/ kg/ day). Raw Raw 5: are are €Road Road 15:Row 16:\nRowRow 17:\noutcomes outcomes (QALY) life-years life-years (LYG). follow-up. follow-up. ROWTERM% at 2 12",
      "start_page": 172,
      "end_page": 172
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "the the anti-tumour(s) control control and/ survival survival (status status 0-1), ROW ROW 7:Row 8:\nRecommendation-1Row 9:\nRationale/ RowRow 10:\ncondition condition Row_M",
      "start_page": 173,
      "end_page": 173
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nradiotherapy radiotherapy (Formenti, 2018; Ngwa, 2018). stage stage III; provided by Rowter-Arcer-Raw 7: ConclusionsRow 8:\n Row 9:\nRaw Raw 6: ~ survival survival rowterm(s) Rowster-Rovert",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: safety safety (and and toxicity) Rov Rov 6: very lowraw 7: grade Road 8: ́Sources: (Butts, 2014) • syndrome syndrome • imaging imaging • Sponsor: group. group. #Row 18:\n Row 19:\nfield. field.",
      "start_page": 175,
      "end_page": 175
    },
    {
      "heading": "headed headed Startpage - lung lung carcinoma (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\n• ROW ROW 5: row 6: ResultsRow 7:\nRowRow 8:\nsurvival survival (critical outcome) Road 9: study study (Antonia, 2017; Antonia, 2018) 51 51 (95% 0. 0.63) RowRow 16:\n Row 17:\nROW ROW 18: the the 24(%) baseline. baseline.",
      "start_page": 176,
      "end_page": 176
    },
    {
      "heading": "headed headed of of life",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: row 5: ROW ROW 6: (95% 1. 1.51)) . patients patients (4.4%) and and gezichtspunt; patients patients (6.0%) placebo placebo (74 74 (95% 1. 1.43) . Rov 7: Row_ 8: equal equal (22.2%) . Overall survival (critical outcome)Row 21:\nThe START-study (Butts, 2014; Mitchells, 2014) median median __MEDTERM4(the the study) μths μths (95% 29. 29.4) months months (95% 25. 25.4%) 0. 0.0% ratio hr2 (24.6% ratio • kg/ kg/ day) • rob.",
      "start_page": 177,
      "end_page": 177
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: ROW ROW 5: RowRow 6:\nRoad 7: 5. Safety (and and toxicity)Row 8:\nunit unit (respiratory distress syndrome) {MM-YY} {15 15 (1%) 5 5 (1%) group group (40 40 (95% 3. 3.82).Row 13:\n Row 14:\npatients patients (4%) patients patients (7%) placebo placebo (61 61 (95% CI 0.45) • velocity velocity • roar • east side • artery artery • region region • west",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nI:(intervention) adjuvant immunotherapy;Row 2:\n Row 3:\non on 23-01-2025 178/428",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nC:(comparison) placebo or observation;Row 6:\nO:",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nmaking making process; safety safety (and and toxicity) Road Road 4: ROW 5: ratio ratio ===0.0) Rovijks: Overall risk-of-disclosure",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nselect select (Methods)Row 3:\nMedline Medline (via OVID) between between (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). contraindications. contraindications.",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n3- Brahmer, J., L. L., Boss, P., Crino, L., E. E., Poddubskaya, E., et al. (2015). __",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nMedicine, 373(2), 123-135.Row 6:\n4",
      "start_page": 180,
      "end_page": 180
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 180/428",
      "start_page": 180,
      "end_page": 180
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW ROW 2: • carcinoma carcinoma - RowRow 3:\n• ROW 4: • Radishing circumstances (ROW: • polycythaemia polycythaemia virus). • recommended. recommended. •Row 8:\nRecommendationRow 9:\n Row 10:\n~ developing developing lymphoma",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\non on 23-01-2025 181/428",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: lung lung carcinoma'Row 5:\ntumor (subclavian subclavian vessels) a a pathologic-lung lung cancer/Row 5:\nchemo-Dummy: a a repeat-Rescue-Lung Lung Carcinoma/ROW 5: Tumour (were were 27% stage IIB, 8% stage IIIA, 42% and and 23% was was 39%. patients patients (66%) is is similar; surrogate surrogate sulcus-tumour",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\non on 23-01-2025 182/428",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nRowRow 5:\n Row 6:\nReferencesRow 7:\n Row 8:\n1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n3- Cancer Cancer 30:RowRow 2:\n4",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nBiol Phys 48:347-354Row 2:\n7",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n9Row 2:\nChest 124:996-1003,Row 3:\n1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n2(7):603-612Row 2:\n1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 183/428",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nbased based (May 2011) question worked out:Row 7:\nstage stage III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n_MEDTERM1_?Row 2:\n Row 3:\nmodule module 'sequential sequential chemoradiotherapy' guideline _May 2011). the the question:Row 4:\nradiotherapy radiotherapy treatment?Row 5:\nRoad 6: ~Row 7:\nRecommendationRow 8:\n−Row 9:\npatients patients _",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\nstage stage IIIA/ RowRow 3:\n Row 4:\nRecommendations consensus based(2013)Row 5:\nwith with ≥ 10 mg/ kg/ day (5. 5.1). of of Row",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n_MEDTERM0_?Row 2:\nRowRow 3:\n Row 4:\nBuildingRow 5:\n Row 6:\nConclusionsRow 7:\n Row 8:\non on 23-01-2025 184/428Row 9:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 1)",
      "text": "Recommendation 1: ROW ROW 2: carcinoma carcinoma - Co-chemotherapyRow 3:\n Row 4:\nRaw Raw 6: Rrow Rrow 7: Rway Rway 8: __MEDTERM3_?Row 9:\n_MEDTERTM3__? ROW 10: RAY 11: module module 'Concomitant versus sewer' ROW: Row",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\n Row 6:\nence based (May 2011) worked-up question:Row 7:\nRowRow 8:\n Row 9:\n Row 10:\nequemental chemoradiotherapy' ROW ROW 11: RowRow 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\nadiotherapy vs. row:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\num III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 3)",
      "text": "Row 1:\n Row 2:\n2011).Row 3:\neling?Row 4:\nrow 5: row 6:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 3)",
      "text": "Row 1:\na row 2: row 3: row 4: orcion too eling? row 5: eling row 6: row 7: row 8: row row 9: row 10: row 11: row 12: um III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (column column 3)",
      "text": "Row 1:\nIotherapyRow 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n184/428",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nstage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n___MEDTERM4_?Row 2:\n Row 3:\nConclusions evidence-based(2011)Row 4:\nstage stage IIIA/RowRow 5:\nAuperin Auperin 2010( 10) row 6: row 7: Conclusions consensus based(2013) Rovter'to to ro",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nSchwartz 2005(51)Row 2:\n Row 3:\nRowRow 4:\nChen 2013(46), Uyterlinde 2013('41')Row 5:\nrow 6: RowRow 7:\n-Row 8:\nstage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nevidence evidence based'Row 2:\n Row 3:\nRowRow 4:\nchemotherapy chemotherapy (radiation radiation therapy) Rod(A&M] at at 2%%%%.",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nROW ROW 4: {ROW} Prior to ́s up-RowTerma RowTerma ́? ROWTER ́ ROWTler ROWTler RawTerm",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nstage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\nat at __",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nstage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\nngcarcinomasRow 3:\nthe the radiotherapy) confirmed confirmed [Auperin row 4: row 5: stage stage bell) [Furuse 1999(61); Curran 2003(59); Zatloukal row 6: 185/428",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRaw 3: row 4: Road 5: ROW ROW 6: 2004(68); Fournel 2005(60); Belderbos 2007(57); Ulutin 2000(67); Clamon 1994(58)]. declined declined [Auperin 2010(S) stage stage IIIA/IIIB {considered. considered.'Row 7:\n Row 8:\ncombinationROW combinationROW 9: to to older'sRow 10:\non on 23-01-2025 186/428Row 11:",
      "start_page": 186,
      "end_page": 186
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: Role 5: daily daily (inter) para_MEDTERM0_ers para_MEDTERM0_ers [Palma 2013a(38), 2013b(39)].Row 22:\n Row 23:\net et al(37)2%)",
      "start_page": 187,
      "end_page": 187
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 5:\nlung lung carcinoma' ROW 6: survival survival [Salama 2013(40); Wang 2012(43); Vancinder 2013(42)]. #Row 7:\nRoad 8: IMRT IMRT [dose dose 2010(49)]. scan scan (RCCT) the the lung'the the L",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW 5: carcinomaROW carcinomaROW 6: et et al(47). [2008] a a [",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nOncol 8:543-555Row 2:\n6",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nPhys Phys 27:507-516Row 2:\n8",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\non on 23-01-2025 189/428Row 2:",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nlung lung cancer: 2010, 28(13):2181-90.Row 6:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nChest 117:358-364Row 2:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRadiother Oncol 52:129-136Row 2:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n165Row 2:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nCancer 41:207-214Row 2:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n20;28(36):5301-10.Row 2:\n1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nChest 117:358-364Row 2:\n2",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nOncol 15(Suppl 7):20-25Row 2:\n Row 3:\non on 23-01-2025 190/428",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n3",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n5'0 - Oncol. Oncol. 2010;20(2):94-106. [link]Row 2:\n5",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 191/428",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: of of non-Phys Phys 2005;62(2):561-70. [link]Row 6:\n5",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 192/428",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - RowRow 3:\n Row 4:\nRaw Raw 5: Road 6: chemoritherapy chemoritherapy (adjuvant adjuvant ~_MEDTERM0__) III-N2 III-N2 ?Row 7:\n• unit unit • RowRow 20:\n Row 21:\nRowRow 22:\n26 26 trials",
      "start_page": 193,
      "end_page": 193
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Eberhardt Eberhardt (2015) in in tumors; / /higher higher risk/other other treatment",
      "start_page": 194,
      "end_page": 194
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nRowRow 5:\nrow 6: Rationale/ Role Role 7: III III - stage stage III-N2_MEDTERM[] on on Rowter-Arm]. since since ≥ difference difference between",
      "start_page": 195,
      "end_page": 195
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Veronica:Row 1:\nrow 2: row 3: row 4: row 4: ROW ROW 5: RowRow 42:\n Row 43:\non on 23-01-2025 196/428",
      "start_page": 196,
      "end_page": 196
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: group. group.'Row 7:\n Row 8:\nrow row 16:Row 17:\nratio ratio (HR) 47 47 (95% 0. 0.96), against against 20depend",
      "start_page": 197,
      "end_page": 197
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: RowRow 6:\n16 16 (7.9%) after after pneumonectomy; to to diarrhea; 4 4 (2.1%) 748 748 1245",
      "start_page": 198,
      "end_page": 198
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nrow 6: RowRow 7:\nRowRow 9:\n~Row 10:\nsecrecy. secrecy.",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\ntrial. trial. • Routine self-esteem • Slowly • Thrombophlebitis • Radishes • Artery • therapy therapy • pain pain • Lung disease • Hemorrhagic nerves • tables. tables.'Row 18:\n Row 19:\non on 23-01-2025 199/428",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nResponsibleRow 4:\nrow 5: Last assessed: 07/07-2020 Road 6: Last authorized: 07-07-2020",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 200/428",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - RowRow 3:\n Row 4:\nsub sub modules: row 5: ~ row 6: { row 7: =treatment treatment • Road Road 8: > 2dline treatment _",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n836Row 2:\n3",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nClin Oncol 26:4617-4625Row 2:\n4",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nInst 95:362-372Row 2:\n5",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n19:1336-1341Row 2:\n6",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 201/428",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nBMJ BMJ 311:RowRow 6:\n1",
      "start_page": 202,
      "end_page": 202
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nOncol 15(Suppl 7):20-25Row 2:\n Row 3:\non on 23-01-2025 202/428",
      "start_page": 202,
      "end_page": 202
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n__EDTERM3_Row __EDTERM3_Row 3:\n Row 4:\nRowRow 5:\n Row 6:\ntreatment treatment (primary treatment) of patients ___",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: rare mutation).Row 3:\nPD-L1 PD-L1 ≥50% primary__",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nROW ROW 5: status status (_MENTERM39__ ≤1), of of >ROW ROW 8:Row 9:\ntreatment treatment __MEDTERM15_'study study (Paz-Ares, 2018) on on a",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nthe the study'trial-Raw trial-Raw 4: combination combination carbo- study study (Socinski, 2018), immunotherapy immunotherapy (Davies, 2017; Lazzari, 2017). RowRow 11:\n Row 12:\non on 23-01-2025 205/428 Rod",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nROW ROW 4:Row 5:\nthe the patient'cell-celled cell-celled evidence- ROW 12:Row 13:\nnon-squamous non-squamous cell-like;of of 1-49% both both immunotherapy/the the ke",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nRoad 4: RowRow 5:\nRowRow 7:\npatients patients **of of {G] and {C] individual individual benefit/ Union Union (EU) RowRow 18:\non on 23-01-2025 207/428Row 19:",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "This This includes: risk-benefit risk-benefit analysis",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nRowRow 4:\nRoad Road 5: row 6: ROW ROW 14:Row 15:\ncombination combination carboplatin-paclitaxel-_MED-_MEPTERN therapy- is slightly limited-rather-Administered-ROVED-ROWER-Divert-Live-Two-Mife-Towards-Over 1-Device-Boxed-Covator-Lead-Mivert/Soft-Wivent-Fiveth-Early-Paclizumab-Iive-Home",
      "start_page": 209,
      "end_page": 209
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nRowRow 4:\nRoad 5: row row 6:Row 7:\nof of care;_",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: • ROW ROW 5: ratio ratio ≥50%, RowRow 6:\ńRomânia România Roww",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\npemetrexed)Row 2:\nnonsquamous nonsquamous non-RowRow 3:\nLowRow 4:\nGRADE ROW 5:Row 6:\nwith row 7: •1, •and and • Row.",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\n Row 3:\nrow 4: • ROW ROW 5: cancer. cancer. •Row 6:\n• Moderate-Row 7:\n− of of it; −",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\nrow 3:Row 4:\n• ROW ROW 5: safety safety (and and toxicity) cancer. cancer. •Row 6:\n• Very low ~ ROW 7: −GRADEROW 8 • Row_ Comité-Row",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nROW 3: row 4: RowRow 5:\nin in patients; burden burden ≥10 mutation/MbC. Row:Row 34:\nLowrow 35: ~RowRow 37:\n−Row 38:\n•Reference: (Socinski, 2018)Row 39:\n●Row 40:\n(2)RowRow 45:\nsyndroomRow 47:\nA. A.",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: ROW 4: • cancer cancer • ROW 5: • carcinoma carcinoma • Row territory • row velocity • avoid avoid • haemorrhage • respiratory distress • gait instability • consciousness consciousness • flight risk • disease management • developmental disability • weakness • dystonia • peripheral neuropathy • disease disease • study. study. Row",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 5:\ncarcinomaROW carcinomaROW 6: NSCLC_MCEDTERM0_ NSCLC_MCEDTERM0_ + chemotherapyChemotherapy Road 7: (KEYNOTE- 021)Raw 8:Row 9:\n~ROW 10: Ghandi, 2018 (KEYNOTE- 02): •Rov",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed of of life (column column 1)",
      "text": "Row 1:\nRowRow 2:\nIV IV nonsquamous; RobsterM3_Row RobsterM3_Row 3:\n(KEYNOTE- 021)Row 4:\nnon cow 5: Ghandi, 2018 (KEYNOYE- 189)Double- NSCLC_Row NSCLC_Row 6:\nROW-MENG ROW-MENG SOCH",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n~Row 7:\ńRow 8:\n−RowRow 9:\n-Row 10:\n●Row 11:\nRowRow 12:\nRowRow 13:\n→Row 14:\n=chemo chemo N°2.20: SIFISO 29: Row-A1 ROW",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed of of life (column column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nROW 4: row 5: RowRow 6:\n~ ROW 7: >METERM2_ + 2 2 2+ Row 3+ row 2+",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: survivorship survivorship (Reck, 2016) or or nonsquamous; lifeRow lifeRow 16:\nOne study (Brahmer, 2017) unit. unit. (QLQ-C30) status status (GHS)/quality-of-life (frequently. frequently.'Row 20:\n Row 21:\nRowRow 22:\n~Row 23:\non on 23-01-2025 217/428",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: of of evidence: II. II.'Row 20:\n Row 21:\nGandhi Gandhi (2018) was 69.2% in the __MEDTERM1_+ 49. 49.4% in in the___",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: RowRow 5:\nRoad 6: Z: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: confident interva'lRow 7:\ńRow 8:\nGhandi (2018) Langer Langer (22), Group. Group.'Row 12:\n Row 13:\n52 52 (95% 0. 0.62), death. death.",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nZ: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: RowRow 4:\nrow 5: Gandhi (2018) with with (95% 0. 0.45) 0. 0.9% (Royal pain score:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: RowRow 7:\nTwo studies (Gandhi, 2018; Langer, 2016) 48. 48.5% Five Five (26%) to to 49% and 16 (80%) of of 50% of of 49% (39%) greater greater (35) Row",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\ndRow 2:\n Row 3:\n Row 4:\nrow 5: ROW ROW 6: (n=133) group group (RR 1.02; 95% 1. 1.15). In 6.7% (n=27) 5. 5.9% (n=2) Road Road 7: ́evidence. evidence.'Row 16:\n Row 17:\ninconsistentness inconsistentness (across across studies) clinical clinical relevance).",
      "start_page": 221,
      "end_page": 221
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: evidence. evidence. •Row 8:\n__MEDTERM0_with chemotherapy (carboplatin/paclitaxel) with with stave/PQQ-T-R-I-V-91 91 (95% 1. 1.06), favoring ipilimumab_(figure 5) RowRow 13:\n Row 14:\nFigure 5 Overallsurvival__azolamcm1; RowRow 15:\ńRow 14:\nOverall Overall survivor(S)",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nsurvival survival (or or death) chemotherapy chemotherapy versus",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nchemotherapyRow 2:\n Row 3:\nZ: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: 4 4 : RovMED 5 : 6 6 : comparing comparing ___ThenTERM0_+ rate rate (Govindan, 2017; patient patient ___",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: row 5: carcinomaRow carcinomaRow 6:\n54. 54.2% evidence. evidence.'Row 14:\n Row 15:\ndeath. death.",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: industry industry (risk of bias), results results (stevigs stevigs studies) clinical clinical relevance) Hellmann Hellmann (2018) Burden Burden (TMB) ≥10 Mutations/Mb and ≥1% Expression Expression (PD PD -of of <1% to to receive;",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: confidence interva'l'Row 8:\nrateRow rateRow 9:\nOne study (Carbone, 2017) approximately approximately 18% versus versus 41% group group (RR 0.43; 95% 0. 0.64) (Carbone, 2017; Hellmann, 2018), 10. 10.'Row 16:\n Row 17:\nSafety Safety (and and toxicity) __",
      "start_page": 226,
      "end_page": 226
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: carcinoma carcinoma convulsion'Row 5:\nRoad 6: ́Row 7:\n~Row 8:\nZ: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: RowRow 9:\n− Rov 10: chemotherapy chemotherapy level: Overall survival (critical outcome)Row 23:\nstudy study (Hellmann, 2018) to to Row25-24:",
      "start_page": 227,
      "end_page": 227
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: RowRow 5:\nRoad 6: survival survival 7: PD PD -least least 1% (62 62 (95% 0. 0.85) confidence confidence ratio: Row",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nof of evidence: RowRow 6:\n Row 7:\nof of evidence; Road 8: of of life--it wasn'consciousness. consciousness.",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\npaclitaxel (BCP)Row 2:\nsurvivalRow survivalRow 3:\n1 1 (Socinski, 2018). genotype genotype (WT population; expression expression (on on <50% and and <10% immune immune cells), BCP BCP (68 68 (95% to to .82). high high PD- L1 ratio: Row.",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: cancerRow cancerRow 5:\nRoad 6: lifeRaw lifeRaw 7: life. life.'Row 8:\ńRow 9:\n5. Safety (and and toxicity)ROW 10: evidence. evidence.'Row 14:\n Row 15:\nevidence. evidence.' ROW 16: #Row 17:\n#equal. equal.",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nchemotherapyRow 2:\n Row 3:\non on 23-01-2025 230/428Row 4:",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: lungrow lungrow 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: RowRow 7:\n−Row 8:\nselectingRow selectingRow 9:\n~Row 10:\nabove. above.",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nI (intervention)immunetherapy with PD-1-, PD-L1- inhibitors inhibitors (without without chemotherapy);Row 2:\nC (comparison) platinum-based doublet chemotherapy;Row 3:\n Row 4:\non on 23-01-2025 231/428",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed of of life (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nZ: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: confideRow 4:\n Row 5:\nRowRow 6:\n Row 7:\naccompaniing accompaniing PICO:Row 8:\n Row 9:\nneck. neck.",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed of of life (column column 1)",
      "text": "Row 1:\nI (intervention)immuneotherapy with PD-1-, PD-L1- inhibitors inhibitors (RowRow 2:\nC (comparison) platinum-based doublet chemotherapy;Row 3:\n Row 4:\non on 23-01-2025",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed of of life (column column 2)",
      "text": "Row 1:\n Row 2:\nRoy 3: row row 4: row 5: ROY 6: ~Roy 7: g researchRaw 8: −Row 9:\nhibitors (andROW andROW 10:",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: • O (outcome) • life, safety; •Row 6:\n− Raw 7: measures measures −Row 8:\nmeasure measure − difficulties difficulties − risk risk − factors factors − follow-up. follow-up.",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\nselect select (Methods)Row 3:\nMedline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). contraindications contraindications ont(s) .",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\non on 23-01-2025 232/428",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n2",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\non on 23-01-2025 233/428Row 2:",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n2018 2018 Nov/Dec;26(10):701-708. doi: 10.1097/PubMed PubMed PMID: 30095468.Row 6:\n1",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "headed headed of of life (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 234/428",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe",
      "text": "ROW 1: Raw Raw 2: RowRow 3:\n Row 4:\nROW ROW 5: ́ ROW 6: stage stage IIIB/C/IV_METERM26_? ~ ROW 7:Row 8:\nRecommendationROW 9: \\ ROW 10: verwarrenMETERTM26__BAR_ verwarrenMETERTM26__BAR_ (Raw Raw 17:Row 18:\nRow Row 19_: ROW ROW 21: M M <= 2 mg/ kg/ day.",
      "start_page": 235,
      "end_page": 235
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nrow 2:Row 3:\nrow 4: row row 5: IIIB/C/limitations limitations (_MEPTERM4_name selected indirectness) RowRow 6:\nRoad 7: RowRow 8:\n__MEDTERM4_ __MEDTERM4_ PD-L1<1% alone alone + not not provide: Rower Rower CPMP: following following table: Rovello, 2023 (table 1).Row 10:\nrod -Row 11:\nTable 1: chemotherapyROW chemotherapyROW 12: Study Reference/year median _month/11_ (PD-L 1 < 1%) Row-Raw 15 mg",
      "start_page": 236,
      "end_page": 236
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nROW ROW 4: Road Road 6: CostRow 7:\ntreatment treatment __",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nOverallsurvival (critical) PD-L1<1%Row 2:\n_MEDTERM0_% RowTERN1_ RowTERN1_ + or or recurr_METM4(RowTern): uncertain. uncertain.",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nROW 3: row 4: • RowRow 5:\n/ MEDTERM0_ + RowTERM1 combinatie: + or or recurr_rm; rowterM6+ with a PD-L1<1%, uncertain. uncertain. • Rowter: Rowster: • Rawter:",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nPaz-Ares (2021) / Reck (2021 ) / Reck (2023) CheckMate 9L",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 238/428Row 3:",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n__MENTERM0_ __MENTERM0_ (3 3 weeks) week. week.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nResultsRow 3:\n__MEDTERM0_+1 1 & 4: with with patient's with />METM6_ stage IIIB/C/therapy therapy (patients with caregivers) themselves. themselves.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: of of 23% the the context; versus versus 13% PD-L1 PD-L1 <1% cohort (Carbone, 2023). the the \\hood ́RowRow 14:\n Row 15:\nROW ROW 16: PD-L1 <1%Row 17:\nPD PD -of of <1%, rate rate (_MEDTERM6_) was 31.1% (42/135 patients, 95% CI: 39. 39.6) 20. 20.2% (26/129 patients, respectively; 95% facial rate: 28. 28.",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: cancerRow cancerRow 5:\nlifeRaw lifeRaw 6: life. life.'Row 7:\nfor for EQ-2nd. 2nd.",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\npatients patients (93%) RowRow 2:\nassay assay (Paz-",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nAres, 2021).'Row 2:\n Row 3:\nRowRow 4:\nvs. vs. rogue; 10 10 (to to 18-foot-four) . low. low.'Row 14:\n Row 15:\nlimitations limitations (risk of bias: of of fund); applicationability (to to indirectness: reference treatment); involved involved patients-of-life: RoCuW-15. RoCuW-15.",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nRowRow 7:\n Row 8:\nRowRow 9:\n Row 10:\nfollowing following question: the the chemotherapy:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nI:immunotherapy immunotherapy (monoclonal monoclonal antibodies), chemotherapy chemotherapy involvement;Row 2:\nC:single single immunotherapy;Row 3:\nor or equal? • following following criteria:Row 18:\nrow 19:the the PICO; row 20: the the PICOI;Row 21:\ńResearch type: Systematic review; RCT);Row 22:\n~Articles written 26",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nROW ROW 5: cohorts. cohorts.'Row 6:\n Row 7:\ntable. table.'Row 13:\n Row 14:\nGRADE ROW 15: PD-L1 PD-L1 <1% Gandhi Gandhi (2018), Socinski (2018) and Garassino (2023).' ROW 16: rowd. rowd.",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nLast evaluated: 01-01-2023Row 4:\nLast authorized: 24-06-2024",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 244/428",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n2021;24(8):29-34.Row 6:\n1",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 245/428",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n__MDTERM3_Row __MDTERM3_Row 3:\n Row 4:\nRowRow 5:\n Row 6:\nline line (tertiary tertiary treatment) stage stage IIIB/C/IV___EDTERTM3_.Row 7:\n Row 8:\nRecommendationRow 9:\n Row 10:\nto to {months of age}",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nConsider treatment;PD-L1 PD-L1 ≥50%. Road 4: row 5: Consider treatment 7_ELDERM5_~ disease. disease. Row",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: row row 5: However, HEAD-Road_M Road_M 6: Rod Rod 13:Row 14:\nThe cost-Rod Rod 15: practice. practice. A",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nRaw Raw 4: row 5: a a (regional) Road Road 6:Row 7:\nimplementationROW implementationROW 8: patients patients __MEDTERM7/ RowRow 20:\n Row 21:\nConclusions ROW 22: ~ ROW 23: RowRow 24:\nrow-",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica: ROW 1: ROW 2:Row 3:\nrow 4: lung lung ́ ROW 5: / MEDTERM0 ~ chemotherapy chemotherapy non-responder; line line chemotherapy",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica: ROW 1: ROW 2:Row 3:\nrow 4: • lung lung • ROW 5: / MEDTERM0 • chemotherapy. chemotherapy. •Row 7:\n•ModerateRow 8:\n−Row 9:\n~GRADE • Rowter Rowter chemo",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: ROW 4: • lung lung • ROW 5 • •roid 6 • Row necessity • chemoradiance • row45. •RowRow 7:\nLowRow 8:\n~GRADERaw 9: •Raw45 (Raw, Raw45) the the anti-PD-L1 antibody (_",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: CheckMate-017 CheckMate-017 (ReckMate 2-years, 2017), CheckMate-057 (Rekk, 2018) trials trials (Bordoni, 2018). Horn (2017) and Vokes (2018) 10 10 mg/ ROW ROW 22: regimens regimens (combination combination therapy) the provider(s) lung lung cancer_",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5:Row 6:\ndocetaxel docetaxel (HR 0.73; 95% 0. 0.8%). subgroups subgroups 1-49% and ≥50%, 76 76 (95% 0. 0.96) 53 53 (95% 0. 0.70) respectively.Row 18:\n Row 19:\nro. ro. (",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: 15 15 (_MEDTERM0_) 0. 0.81; 07_ 07_ verwarreneterM1_) (figure 3).' ROW 8: − Rov Rov 9:Row 10:\n2 2 − Roval 2 mg/m2 − possible. possible.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: squamous squamous (73 73 (95% 0. 0.98) disease disease (0.73 (95% 0. 0.89), Raw Raw 7: • Row 2 mg/ were were 10% versus versus <1% group group (Vokes, 2018: CheckMATE CheckMATE 057). Road 18: andRow 19:\nprevious previous reporter'2x11. 2x11.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4:Row 5:\ncarcinomaROW carcinomaROW 6: 04 04 (95% 1. 1.27) 59 59 (95% 0. 0.74) nonively.Rov 7:Row 8:\nratio ratio 0;13. 13.8% 13. 13.7% group group (RR 1.01; 95% 2. 2.59).'Row 14:\n Row 15:\nRowRow 16:\n~Row 17:\non on 23-01-2025 256/428",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: RowRow 7:\nyears years (Horn, 2017) years years (Vokes, 2018) arms arms (0. 0.034; 95% CI - 0. 0.076).'Row 16:\n Row 17:\nBordoni (2018) RowRow 18:\non on 23-01-2025 257/428",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nROW ROW 5: Road 6: (OAK trial) EORTC EORTC Quality-alsookrcferfer alsookrcferfer (QLQ-C30). • Ventricular weakness; • Persistence rate • 94 94 (95% 1. 1.24), favoring @_MEDTERM0_. • control control • had had 83% chemotherapy chemotherapy (RR 0.17; 95% 0. 0.25), patients receiving *_EDTERM3___ had 59% by by chemotherapy(RR .41; 95% 0. 0.52) receiving receiving =< patients patients + 25 25 (RR 0.41) received received .",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: lungrow lungrow 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: RowRow 7:\nandRow 8:\nyears years (Horn, 2017) later later (Two years): evidence. evidence.'Row 12:\n Row 13:\n__MEDTERM1_~Row 14:\noutcomes outcomes (clinical clinical relevance).Row 15:\n#Row 16:\nconfidence. confidence.",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: blinding blinding (subjective outcome) outcomes outcomes (events events ). Road 6: level level .",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nI (intervention) immunotherapy with PD-1-, PD-L1- and CTLA4-inhibitors;Row 2:\nC (comparison) chemotherapy; row 3: O (outcome) RowRow 4:\n Row 5:\nROW ROW 6: risk risk ratio:",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nQuality of life: difference difference (MID) VAS VAS (Pickard, 2007).Row 2:\n Row 3:\n Row 4:\non on 23-01-2025 260/428",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: select select (Methods)Row 6:\nMedline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS) other. other.",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 261/428Row 2:",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n2018 2018 Aug;13(8):1156-1170. doi: 10,1016/PubMed PubMed PMID: 29777823.Row 6:\n7:",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 262/428",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\nTreatment following (chemo-)ROW ROW 3: Raw 4: • chemotherapy-Roval chemotherapy-Roval toxicity-Raw: • a a second- and/ doublet doublet (or or sequentially) line line and/or second line? •Row 7:\nRecommendationRow 9:\n Row 10:\npatients patients (months, 95% 9 9 months) (The Langen, 2023) (Treatment Treatment incurable_>METERM22___~ *** RomeTrem5 RomeTrem5 (rarely) extensive extensive description). ROW 19: with with Ro",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: row 5: the the benefit/ clinically clinically relevant",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nUnderbuildingRow 3:\nrow 4: Background row 5: Road 6: chemotherapy chemotherapy (ChT) with immunotherapy (ICI) mutations mutations (for for ICI). rate. rate.",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica: row 1: cow 2: row 3: row row 4:Row 5:\nchemotherapy chemotherapy (without without treatment) themselves. themselves. Rowwter-",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nI:docetaxel;Row 2:\nC:",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nO: RowRow 2:\n Row 3:\nRowRow 4:\ndecision decision making; and progression- oflife oflife questionnaire: Row necessity:",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: clinically clinically (patient) other other (regardless of difference): docetaxel+_MEDTERM0_or docetaxel___medTERM1_) RowRow 25:\n Row 26:\nResultsRow 27:\nliterature. literature.'Row 28:\n~Row 29:\nResponsibleRow 30:\n-Row 31:\nLast assessed 01-01-2023Row 32:\nLast authorized",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 266/428",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n28;28(15):OF1-OF7. doi: 10,1158/1078-0432. CCR-print. print. PMID: 35762926; PMCID: PMC96622947.Row 5:\n2",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 267/428",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - preferable preferable to:limited limited to: RowTERM9_Raw 3: 4 4 Rawter's response to: RovterRovter'__MENTERM0_astases __MENTERM0_astases (1 to 5_MEPTERM0_antibodies) local local therapy;aberration aberration (_MEDTERM6_ or __MDTERM7_), therapy therapy (radiotherapy or surgery) Gomez Gomez (2019), 8 8 months), placebo placebo (4. 4.4).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nIn guidelines (ESMO, NCCN) Gomez Gomez (0-6) and Iyengar (2018).Row 5:\n Row 6:\nROW ROW 7: ROW 8: oligo_METERM0_astases oligo_METERM0_astases (lymph lymph node_MEPTRM0+total, well/driver driver aberrations), treatment treatment (concurrent );therapy therapy . survival survival (_MEDTERM7_) RowRow 15:\non on 23-01-2025 269/428Row 16:",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nGomez Gomez (2019) 0 0 (39. 39.8) Raw Raw 12: RowRow 16:\nthe the benefit/ treatment treatment rod",
      "start_page": 270,
      "end_page": 270
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nROW ROW 5: not not ge_medterM0(RowRow 22:\nLowRow 23:\ńGRADE ROW 24: ~Row 25:\n-Sources: (Gomez, 2016; Iyengar, 2018)Row 26:\n'Row 27:\n−of of (chemo)uiteen. uiteen. Roww",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: RowRow 6:\ngroup (n=24) _MEDTERM2_ _MEDTERM2_ (96% each each patient). regimen regimen (Gomez, 2016) 10 10 : Rong/ Lymph Nodes 1) RT RT + 11 11 : 2 Spleen2",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nROW 2: RowRow 3:\ngroup (n=24) synchronous synchronous oligometastatic;_MEDTERM1_(96% in patients), Roworgan ́ Row",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\nrow 3: and and 92% 2 2 R-R-A-R) 1 1 R-E-R (5 5 R-Trower)",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nh h p). RowRow 4:\n Row 5:\n Row 6:\n Row 7:\nplatinum row 8:Row 9:\n Row 10:\nrow row 11:Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\nplatinumRow 18:\n Row 19:\n Row 20:\n Row 22:\n Row 23:\npy)Row 24:\n Row 25:\ncaties",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\nnRow 8:\n Row 9:\n Row 10:\ncitesRow 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\nn row 18:Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\nsRow 26:\n Row 27:\n Row 28:\nnsRow 29:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\nROW 4: row 5: • carcinoma carcinoma • Rov 6: 141) Two brain lesions*1) RowRow 7:\n2) Lung/lymph nodes2) 8 8 • 15 (7-11) Lung nodules • Lung (0) Lung Lung sp)",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\n141) Two brain lesions*Row 3:\n2) Lung/RowRow 4:\n151) Lung: Row/RowRow 5:\n(2) AdrenalRow 6:\n3) Bone (L4)Row 7:\n131) LiverRow 10:\n171) Bone(S1)Row 11:\ń2 Lung / 12 12 ) L-L. L-L.",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\n*Row 3:\nsRow 4:\nsRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\nesRow 12:\n Row 13:\nes row 14: es ROW 15:Row 16:\n Row 17:\nlesRow 18:\n Row 19:\nes ROW 20:Row 21:\n)Row 22:\n Row 23:\nes Road 24:Row 25:\nRowRow 26:\n Row 27:\nesRow 28:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\nRowRow 26:\n Row 27:\n Row 28:\n Row 29:\n Row 30:\n Row 31:\n Row 32:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\nmetastaRow 26:\n Row 27:\n Row 28:\n Row 29:\n Row 30:\n Row 31:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\n1) RowRow 3:\n2) RowRow 4:\n14, G) 4, 4,",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\nsRow 3:\nnsRow 4:\nRowRow 5:\n Row 6:\n Row 7:\nsRow 8:\nnce Therapy: erlotRow 9:\nns ROW 10: nes RT + pemetreRow 11:\nt (RowRow 12:\nnts RT + PaclitaxRow 13:\nnls RT + pemetreRow 14:\nRowRow 15:\n Row 16:\nionsRow 17:\nslow 18: row.",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:Row 6:\n Row 7:\n Row 8:\n__",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRactionRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nboplaRow 11:\nrapy)Row 12:\nplatinumRow 13:\nboplaRow 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\nposideRow 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\nRowRow 28:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\natin row 11:Row 12:\nnRow 13:\natin row 14:Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\neRow 23:\n Row 24:\n Row 25:\n Row 27:\nx 5)Row 28:\n Row 29:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: row 5: • carcinoma carcinoma • LOW 6: 311) 7 7 • 2 Lung (Primary site) • Row 8 • 321) Brain*9 9 2) Lung disease. • Nung/ 1, Sp",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\n311) Brain*Row 3:\n2) Lung (primary site)Row 4:\n321) BRAIN 5: 2 Lung/ROW ROW 6: 331) Rung/ Row Row / L. L.",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: ns (Hu row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row row 25: row 26: row 27: n row 28: nz* row 29: row 30: row 34:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: umeru row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: 3) row 25: row 26: row 28: row 29: row 30: row 31: row 32: row 27:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\nrow 2: PemeRow 3:\n Row 4:\npeme row 5:Row 6:\ńPeme row 7: ~",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\netrexeRow 3:\n Row 4:\netrexee row 5:Row 6:\netrexEE row 7:Row 8:\nemetrete row 9:Row 10:\netice row 11:Row 12:\nervatio row 13:Row 14:\n__MEDTERM0_ROW 15:Row 16:\nervatio row 17:Row 18:\nrow row 19:Row 20:\nemtrexe row 21:Row 22:\nt_EDTERM02:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\nedRow 3:\nrow 4: row 4: ed row 5: row 6: od row 7: row 8: ed row 9: row 10: ED row 11: row 12: on row 13: row 14: row 15: row 16: on row 17: row 18: rod row 19: row 20: row 21: row 22: row 24: on cow 25: row 26: row 27: row 28:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4:Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 28:\n Row 29:\n Row 30:\n Row 31:\n Row 32:\n35 row 33:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 14)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4:Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\n Row 28:\n Row 29:\n Row 30:\n Row 31:\n Row 32:\n35 row 33:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nROW 3: row 4: Road 5: RowRow 6:\n481) Brain*PemetrexedRow 7:\n2) and 3) RowRow 8:\n491) Lung/Raw Raw 9: −RowRow 10:\n~3) node node − ROW 11: *disease disease ** 6 6 (30. 30.2) months.Row 14:\n Row 15:\nregimen regimen (Iyengar, 2018)Row 16:\nRowRow 17:\n11) Right upper lobe1) 18 18 2) right hilum2) 19 19 ): 3000 3) cm cm 4* Row",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\n481) Brain*Row 3:\n2) and 3) Rowwijk- Lwaich- to to Rowijk: 727 727 Rawijk- l45 Ravijk ́ 347 347 ) 24 24 Rockest",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nrow 2: PemetRow 3:\nesionsrow 4: esPemetRow 5:\n Row 6:\nmph noderow 7: tion.Raw 8: ~Row 9:\ndisease disease (30. 30.2) MONTHS:Row 10:\nRow",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Rofract 1:Row 2:\ntrexedRow 3:\n Row 4:\ntrexed'Row 5:\nrow 6: ́Row 7:\n~ Raw 8: • or or (1) MEDTERM1_ ARY) circl circl ́ arm 15,",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nandRow 12:\ntionRow 13:\ntionsRow 14:\ntionsRow 15:\netaxelRow 16:\ntions ROW 17: IONS ROW 18: __MEDTERM0_ ROW 19: ION ROW 20: plications ROW 21: cw 24:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 26: row 27: row 28: row 29: row 31: row 30: row 25: row 34:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica:Row 1:\nrow 2: row 3: row 4: row 4: row 5: 7, 2) LEFT lung2) 10, 2) Mediastinum ́2) 16, 24",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\n8 row 3:Row 4:\n9 row 5:Row 6:\n10 row 7:Row 8:\n11 row 9:Row 10:\n12 row 11:Row 12:\n13 row 13:Row 14:\n14 row 15:Row 16:\n15 row 17: 16 row 18:Row 19:\n17 row 20:Row 21:\n18 row 22: 19 row 23: 20 row 24:Row 25:\n21 row 26:Row 27:\n22 row 28:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nRowRow 2:\n1) LiverRow 3:\n2) RowRow 4:\n Row 5:\nlobe lobe 6: − 2) 7 7 − 28 28 − 9 9 − essentieel essentieel − Rowsti2) Rowsti) 6 6 − 4 4 − 5 5 − Love.",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 4: e row 6: row 7: row 8: e row 9: row 10: row 11: row 12: row 13: be row 14: be row 15: e row 16: row 17: be rod 18: row 19: row 20: row row 21: row 22: beRow 23:\nrow 24: be cow 26: row 27: eRow 28:\nrow 29: be bow 32:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\nRowRow 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 27:\n Row 28:\n Row 29:\n Row 30:\n Row 31:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: diastin row 21: row 22: row 23: row 24: row 25: row 26: row 27: row 28: row 29: row 30: row 31: row 32: row 35: row 36:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: num row 21: row 22: row 23: row 24: row 25: row 26: row 28: row 29: row 30: row 31: row 32: row 27: row 47:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4:Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 28:\n Row 29:\n Row 30:\n Row 31:\n Row 32:\n35 row 33:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 11)",
      "text": "Row 1:\n Row 2:\n1) RowRow 3:\n2) RowRow 4:\nRowRow 6:\nRowRow 7:\n− 8 8 − 9 9 − 2) 10 10 − 3 − 2, 2600 − 12, −2500 − 1, 1,",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 12)",
      "text": "Row 1:\n Row 2:\nnsRow 3:\nusRow 4:\nrexedRow 5:\nnRow 6:\nusRow 7:\nexedRow 8:\nus row 9: neRow 10:\nns row 11: n row 12: __",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 13)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: dRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 28:\n Row 29:\n Row 30:\n Row 31:\n Row 32:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nRoad 5: ROW ROW 6: 241) RowRow 7:\n251)RowRow 8:\n2)Right hilumRow 9:\n•loBERaw loBERaw 10: 26)Rowwinde Rowwinde (Rovert) the the (chemo)group group (RR 2,30; 95% 5. 5.56).raw 29: row 30: Iyengar (2018) Rov-R. Rov-R.",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\new 3: row 4: RowRow 5:\n Row 6:\nRowRow 7:\nGomez (22) baseline baseline (visit visit (16 16 weeks), treatment treatment (Iyengar, 2018) 6x12 6x12 24* rod rod lP",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: blinding blinding (risk of bias) level level (RowRow 31:\n Row 32:\nselect select (Methods')Row 33:\nMedline Medline (via OVID) and Embase (via Embase. com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). tab tab ́ at at 23/ 4.",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: Raw Raw 6: following following criteria: oligometastatic oligometastatic non-therapy therapy . avoid avoid .",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 280/428",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - Raw Raw 8: Row Row 2nd",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n1 - advanced advanced non-small-Row 6:\n Row 7:\non on 23-01-2025 281/428",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: cell lung cancer: Oncol Oncol 2005;23:2926-2936.Row 5:\n2",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 282/428",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\ncell lung cancer: RowRow 5:\n2",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:\n Row 7:\n5",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\nrow 2:Row 3:\nrow 4: Oncol Oncol 2005;23Row 5:\nCancer Cancer 2005;49:289-Raw 6: 2005, 49:289-",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n3:2926-2936.Row 5:\nRowRow 6:\n-298Row 7:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n.Row 5:\neatmeRow 6:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nadvancRow 6:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n282/428",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nbe be considered?Row 7:\nRecommendationRow 9:\nRaw 10: be be combined;RowRow 26:\non on 23-01-2025 283/428Row 27:",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nROW ROW 5: and and 20%. is is 6% (95% CI., 2-10%) agents agents (2). the the carboplatin/paclitaxel/ carboplatin carboplatin / paclitaxel-arm (HR 0.79; 95% 67-0. 67-0.92; p=0.003). respectively respectively (HR 0.66; 95% 57-0. 57-0.77; p<0.001), was was 35% and 15% (P<0.001), a a placebo-naïve",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: Rov 5: Raw Raw 6: __MEDTERM0_ __MEDTERM0_ (36% versus 29%, p=0.012), seen seen (months, p=0.04). patients patients __",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n21:3016-3024,Row 2:\n6",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nClin Oncol 2009;27:3217-3224Row 2:\n7",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n2005;47:69-80Row 2:\n8- Clin Clin 122; RowRow 3:\n9N EnglJ",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 285/428",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n1Row 5:\nC",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nN, N,Manegold",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 286/428",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - RowRow 3:\n Row 4:\n• RowRow 5:\nRoad 6: STAMP STAMP ROWTER_Study: • score score (PS) 2? Rov 8: monochemotherapy monochemotherapy (6) (7).Row 26:\n(7Row 27:\n Row 28:\nResponsibleRow 29:\n-Row 30:\nLast assessed 22-05-2011Row 31:\nLast authorized: 22/05-2011",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\non on 23-01-2025 287/428",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n1",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nClin Oncol 26:4617-4625Row 2:\n4",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 288/428",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: lung lung carcinoma'Row 2:\nNSCLC_ NSCLC_ __METERM21__~_# a patient'of of self-retardation/disability/disordering/disappearance-of-disability-disorderedness/distress/distention-displacement:ROWER-disease-display-discussing-discussion-discretion-discomfort-disposition-diskus/disk-dis pneumonia/__MEDTERM10_ __MEDTERM10_ (7 7 study) the the 3rd-months",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: RowRow 5:\nlung lung carcinoma/The The {between between first-generation-_MEDTM29_-TKIs and {the the second-lined-disordered- of of __EDTERM29_-TKI's. ROW 9: studies studies ___METERM30_>__MENTERM29_ __MENTERM29_ TKI'S. For _MEPTERM1_~ better self-effic",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: lung lung carcinoma' ROW 5: trial trial (Janne, 2023). __MENTERM0_ __MENTERM0_ + chemotherapy arm (n=279) or the _SERM_0_%Q. IMPROVED: by by ___mg/ the the AMI+the the patient'Road Road 7:Row 8:\npatients patients (their their caregivers) ROW 9: patients patients {specific specific risk/RowRow 13:\non on 23-01-2025 291/428Row 14:",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nrow 2:Row 3:\nrow 4: row row 5: Road Road 6:Row 7:\nROW ROW 8: survival survival (_",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: TKIs TKIs (ROW ROW 22: ROW 23: ~ ROW 24: ́LowRow 25:\n=GRADE_ROW 26: -Source: Wu, 2017; Ramalingam, 2020; ROW ROW 27: − ROW 28: }TKI TKI (___MEDTERM3_ or _",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nlonrow lonrow 2: row 3: raw 4: row 5: lowrow 6: ~GRADErow 7:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nngcarcinoma'Row 2:\nTKIs TKIs (_Row 26:\n Row 27:\n~Row 28:\ńRow 29:\n−Row 30:\nvermijdenRow 31:\n=Row 32:\n-source: Nakagawa, 2019; Hosomi 2020; Saito, 2019); RowRow 33:\n>Row 34:\n(thereafter. thereafter.",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica:Row 1:\nROW 2:Row 3:\nrow 4: RowRow 5:\nTKI TKI (___METERM0_ or __MEDTERM1_) + other treatment (RowRow 35:\nRowRow 36:\n(RowRow 37:\nYear)Row 38:\n2nd/TKIROW TKIROW 39: III III studyRD_",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: Rowmet ́ R ROWLET ́ ROW ROW 6: naive naive patients(s) metastatic metastatic * ROWMETERM9 (L858R. L858R. 21% daily. daily. ~ C__mg ___Rowmet 2",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "ROW 1: ROW ROW 2: or or metastatic(L858R. L858R. 21% metastases. metastases. / / daily. daily. C1: daily daily n=183Row 3:\n(Rowster-B. Rowster-B.",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: Road 5: b row 6: row 7: ~ row 8: {row 9: }",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n_MEDTERM0_ROW 4: %EDTERM1_ (RowRow 5:\n/%EDterM2_%:Row 6:\n~AEsRow 7:\n≥Row 8:\n>ROW 9: _MEDTERME0_(primaryoutcomRow 10:\n===",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\ny me)Raw 5:Row 6:\n~Row 7:\ń",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Veronica:Row 1:\n Row 2:\n Row 3:\nRoad 4: row 5: ROW ROW 6: relapsed relapsed nonsquamous; X-ray X-ray 13M-M-D-R-T-I-S. (",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nMiyauch 2022)Row 5:\n Row 6:\nNEJ026Row 7:\n(RowRow 8:\n Row 9:\nRoad Road 10: (row row 11:Row 12:\n Row 13:\n Row 14:\nRowRow 15:\n(Piccirillo 2022) Road 16:Row 17:\n Row 18:\nPDF on",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nmi,Row 4:\nhi,Row 5:\nROW 6: RowRow 7:\n2019)Raw 8: ~Row 9:\n−Row 10:\nIS- RowRow 11:\n2021)row 12:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\ninomaRow 2:\nrow row 3:Row 4:\nrow 5: 3 3 study'row row 6: Road 7: EG8 EG8 : andimized, nti",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "ROW 1: ROW 2: utations utations (and and L861Q)_",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n3 row 4:Row 5:\nRowRow 6:\n4 row 7:Row 8:\nni b g/dayRow 9:\n4Row 10:\n Row 11:\n Row 12:\nRowRow 13:\n Row 14:\n Row 15:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\nROW 6: ~Row 7:\n−Row 8:\n4)Row 9:\n●Row 10:\n♦Row 11:\n↔Row 12:\nyrow 13: grofRow 14:\n→Row 15:\n_Row 16:\nadequaat 17: ATCROW 18: 57/Row 19:\nphenoxyRow 20:\nРrow 21: SIFISO 22:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\n Row 2:\nrow 3: _MEDTERM0_ (RowRow 4:\n/EDTERM1_ (row row 5: ~_MEPTERM2_ : ROW 6: AES ROW 7: ___MEPTERN3_Row 9:\ńROW 10: _MEPTRM1_ ~omvat omvat MEPTern>MEPTIR: Row(MEPTORM2)",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 8)",
      "text": "Row 1:\n Row 2:\nLow row 3: y me)Row 4:\n Row 5:\ny ME) ROW 6:Row 7:\n~Row 8:\ń",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nOS: Overall Survival; __ELDERM1_: Progression free survival; _ELDERM2_: Objective response rate; AEs: Adverse events;",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n_MEDTERM0_: LifeRaw LifeRaw 2: Roy 3: Wu (2017) / Mok (2018) /Patty (2021) /Mok(2021) - ARCHER 1050",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nSoria(2018)/Ramalingam (2020)/Leighl (2020). FLAURA",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nPark (15)/Paz-Ares- LUX-Lung 7",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nNakagawa (2019) / Nadal (2021) / Yoh (2020) - RELAY",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nHosomi (2020)/ Miyauchi (2022) - NEJ009",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nSaito (2019) - NEJ026",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\non on 23-01-2025 297/428Row 4:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nZhou (2021) - ARTEMIS-CtronG1509",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nPiccirillo (2022) - The BEVERLY study",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nResultsRow 3:\n Row 4:\nOverall survival - ROW ROW 5: survival. survival. #Row 6:\n#Raw 7: #Three trials (and and LUX-7) study study (Nakagawa 2019). occured. occured.'Row 11:\n Row 12:\n~Row 13:\non on 23-01-2025 298/428Row 14:\n−",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\nversus versus first",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: TKI TKI + ROW ROW 2:Row 3:\nsurvival survival (_MEDTERM0_) - RowRow 4:\non on _",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nversus versus first",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "ROW 1: TKI TKI + ROW ROW 2:Row 3:\nsurvival survival (_MEDTERM0_) - RowRow 4:\non on __",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\ntion",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\nrow row 3:Row 4:\n Row 5:\n299/428",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\nthird third generation",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: TKI TKI + generation generation TKI'Row 2:\n Row 3:\nrate rate (___ 39%eral M___) - Imported outcomeRow 4:\nfrom from 56% to 84%.'Row 5:\n Row 6:\nThree studies (and and LUX-Lung-7) and and 10*.",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\nor or third",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: TKI TKI + ROW ROW 2:Row 3:\nAdverse events (AEs) grade ≥ 3- RowRow 4:\nfrom from 34% to 57%.Row 5:\nRoad 6: Three studies (and and LUX-Lung-7) genesis. genesis.",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nrow 6: events events grade≥or or third",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: TKI TKI + generations generations TKI' ROW 2:Row 3:\nlife life (_MEDTERM13_) - RowRow 13:\nThree studies (and and LUX-7) 77 77 (SE=0.01) 80 80 (SE = 0.01) with__EDTERM1_ with__EDTERM1_ (p=0.14). Road 5:Row 6:\nFour studies (RELAY RELAY study) RowRow 7:\non on 23-01-2025 302/428 ROW:",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\nTKI TKI + Generation Generation TKI",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nstudy study (NEJ026) on on patients' RowRow 3:\nrow 4: the the literature'Row 5:\nof of evidence: evidence. evidence. #Row 6:\nROW 7: __MEDTERM0 % cm. cm.",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: RowRow 5:\nRoad 6: limitations limitations (risk of bias: the the sponsor); imprecision (relevant relevant effect). RowRow 7:\nlevel level (Row 13) low. low.'Row 16:\n Row 17:\nRowRow 18:\n~Row 19:\nfollowing following question:'Row 20:\ninhibitors inhibitors (_",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nI:treatment treatment with:Row 2:\n1) inhibitors inhibitors (_MEDTERM0_, _>MEPTERM1_,Row 3:\n_",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: cancerRow cancerRow 5:\nOverall survival: >16 weeksandHR<0.7Raw 6: − Progression-free survival: <=16 week & −HR<RowRow 7:\n+ Objective response rate: absolute difference >10%ROW 8: Adult events: absolute differences <5% for lethal complications- 1x22. 1x22.",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nUpdated search'Row 3:\nand and Obsid/analysis. analysis.'Row 8:\n Row 9:\nfollowing following criteria:'Row 10:\n~Row 11:\non on 23-01-2025 305/428Row 12:\n=",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: ROW ROW 5: phase phase III; row 6: −stage stage IIIB/___MEDTERM0_ ___MEDTERM0_ mutation; −Row 7 −line line treatment;language. language. −Row 37:\nopposite, opposite,",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 306/428Row 2:",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n8",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 307/428Row 2:",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nwith with __",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 308/428",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW ROW 2: NSCLC_METERM2_ NSCLC_METERM2_ (rarely) mutationsRow 3:\n Row 4:\nRowRow 5:\n~ ROW 6: Which (new) RowRow 26:\nRowRow 27:\nROW 28: to to *by by Ro",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "ROW 1: ROW ROW 2: __MEDERM2_ __MEDERM2_ (rarely) mutationsRow 3:\n Row 4:\nRowRow 5:\nRoad 6: Which (new) an an incurable_>>METM34_## RowRow 28:\n Row 29:\nROW ROW 30: ~ ROW 31: BRAF, _METER",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: EGFRRow EGFRRow 7:\nrow 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: ___EDTERM2___, or nen: _",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: lung lung carcinoma' ROW 5: tumor-specific tumor-specific abnormalities: and and fusion/rearrangements in ~Road Road 12: Raw 13: patients patients (their their caregivers) ROW 14: __MENTERM5_: drip drip 15_METER2",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nROW ROW 4: patients patients __MEDTERM0_% Boards Boards (MTB)Row 5:\nRaw 6: Rationale/the the ROWTER",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: arrow 5: Row Row Rway: Search Search period: stabilised stabilised randomised;fusions. fusions. A: ___ 39%",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nPDF on",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\n Row 5:\n9 RCTs (ROW 6: ́A:eXALT Road 7: ~B:ALTARow 8:\n≥C:CROW",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\nparalysis. paralysis. period: RowRow 3:\nRoad 4: row 5: (phase III):Row 6:\nRowRow 7:\nRoad Road 8: RowRow 9:\nrow row 10: row row 11: FILE1029 row 12: row row 13: row row 14: ILE1014:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n~ row row 3:Row 4:\n Row 5:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\nmentally anced LKA:Row 3:\nrow 4: I: bid bid N=172H:Row 5:\nI: Pemetrexed 500 mg/m2 + cisplatin 75 mg/ mg mg / m2 + carboplatin (AUC 5 6) N=171",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\nB: bid bid N=138Row 2:\nC.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\nROW 6: ~Row 7:\n−Row 8:\n4)Row 9:\n0 5ROW 10: 0587Raw 11: =Row 12:\n=0:0 5row 13: ↔ -Row 14:\n-",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 8)",
      "text": "Row 1:\n Row 2:\nrow 3: _",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nROW 2:Row 3:\nrow 4: Road 5: Raw Raw 6: aged aged ≥ with with KRASG12C- mutant advanced;platinum-based platinum-based platinum- mg mg • Row",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nGerber,Row 5:\n2018Row 6:\n Row 7:\nNCT013Row 8:\n Row 9:\n__MEDTERM0_ROW 10: RowRow 11:\nBRAFRow 12:\nRowRow 13:\n_MEDTERM1_Row 14:\nRowRow 15:\n_EDTERM2_Row 16:\nROW 17: PDF on.",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nRowRow 2:\ncountries countries ́ Rowforcer' Rowracer'Rowager'A randomization ́",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\nnous xel (row row 3:Row 4:\nRowRow 5:\n Row 6:\n Row 7:\nRowRow 8:\n Row 9:\nrow row 10:Row 11:\nettherap row 12:Row 13:",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n3Row 3:\n_MEDTERM0_Raw 4: ___MEDTERM1_Row 5:\nRowRow 6:\n~Row 7:\ńSafetyRow 8:\n−PROsRow 9:\n-raw 10: -Row 11:\n=_MENTERM0_ROW 12:",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row_s 1:Row 2:\n Row 4:\nrow 5: ROW ROW 6: a a _",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nHer2Row 5:\nRowRow 6:\n Row 7:\n__MEDTERM0_Row 8:\nRowRow 9:\nNRGRow 10:\n Row 11:\nPDF on",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nrow 4: row 4; row 5: Search period:Row 6:\ńIncluded Included studies: 2RedRRMC 2RedRRMC RowR-R",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 3)",
      "text": "Row 1:\n Row 2:\na a __",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 7)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\nROW 6: ~Row 7:\n−Row 8:\n4)Row 9:\n●Row 10:\n♦Row 11:\ngrofRow 12:\n↔Row 13:\n(2)Row 14:\npy and 3)Row 15:\nextreemRow 16:\nPPA",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 8)",
      "text": "Row 1:\n Row 2:\nrow 3: _",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nROW ROW 6: or or __",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nC:Control)= or or __",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nmeasure measure Row: row: RowRow 4:\n Row 5:\nasthma asthma (r) .",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "ROW 1: ROW ROW 2: RowRow 3:\nUncommend≤M27_ mutation /_",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\ndecision decision making; measure. measure. #Row 4:\n Row 5:\nfactors factors (ROW:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (column column 2)",
      "text": "Row 1:\n Row 2:\nmentRow 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:\n Row 11:\n Row 12:\nb; RowRow 13:\n Row 14:\nndRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Rowschleel 1:Row 2:\n Row 3:\nRoad 4: row 5: ROW ROW 6: Objective response rate: available available (non-randomized non-randomized studies)-Row 7:\nabsolute difference <5% or or <25% for serial complications'Row 8:\ńlife life self-reported: excluded. excluded.'Row 16:\n Row 17:\nexcluded excluded (tab tab methods). penguin, 2022; Xu, 2022). other. other.",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 316/428",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n2",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\non on 23-01-2025 317/428Row 2:",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nMar Mar 15;28(6):1117-1126. doi: 10,1158/1078-0432. CCR-21-2733. PMID: 34789481; PMCID: PMC9365370.Row 6:\n1",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "headed headed immunotherapy. immunotherapy. Severe (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 318/428",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading _MEDTERM0_:",
      "text": "ROW 1: RowRow 2:\n__MEDTERM12_fusesRow 3:\n Row 4:\nRowRow 5:\nROW 6: Which (new) to to _MEDRM12_fusions? ~ ROW 8: row row 10: better better outcomes;_",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nRowRow 7:\ngeneration generation ~_",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: RowRow 5:\nRoad 6: analysis. analysis.'Row 7:\n~Row 8:\nRowRow 9:\nPeng (2023)",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "#Row 1:\npublished/unpublished phase 2/advanced advanced (III/IV/recurrent) # Peng Peng (2023).Row 2:\n Row 3:\nStudyStudy designPatientsInterventionControlReported-Follow-upRow 13mg: Österreich Rowd-Mead Otherwise-Med(S-M-D-Q-Ten)(n-Two-",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: ROW 5: Raw Raw 6: or or ≥20 years_MED_",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 1)",
      "text": "Row 1:\nlung lung cancer'Row 2:\nor or ≥20 years (local local regulations) advanced advanced __MEDTERM3_- RowRow 3:\nRow 4 : 5 5 : N=149 cm Rowterm1",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\n Row 2:\nbid bid N=147Row 3:\n Row 4:\nROW 5: N N =151Row 6:\nrow 7: ~Row 8:\no___MEPTRM0___ + RowRow 9:\n=N=62Row 10:\n−Row 11:\n≥",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n Row 2:\n___",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n__MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4:\nSafeRow 5:\n__ELDERM3_",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n__MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4:\nAEs",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n__MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4:\nSafe",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSRow 4:\n Row 5:\nRRow 6:\netyRow 7:\nLRow 8:\n Row 9:\n Row 10:\nSRow 11:\n Row 12:\nR Road 13: sRow 14:\n Row 15:\n Row 16:\nS row 17: R row 18:Row 19:\new 20:Row 21:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4:Row 5:\nI: 7 7 C: 13 13 Produto) investigator-assessed investigator-assessed 15(M) 24 24 . Row 12 Comité",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: • ROW ROW 6: trial. trial. • of of life",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 1)",
      "text": "Row 1:\nrow row 2: row row 3:Row 4:\nJ2-ALEX row 5:Row 6:\nrow row 7:Row 8:\nPROFILE row 9:Row 10:\n Row 11:\nPDF gem",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\nRowRow 2:\n_MEDTERM2_ _MEDTERM2_ inhibitor- advanced advanced non-were were chemotherapy- regimen regimen ); {MMD] Row",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n Row 2:\nbid bid N=1Row 3:\nrow 4: arrow 5: mg mg + cispla 75 mg/ mg mg + carbopl (AUC 5 N=103Row 6:\nRoad 7:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 4)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nrexed g/m2 atin /m2 rexted g/ m2 latin 56)Row 5:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\n__",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n__MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4:\nRowRow 5:\nSafe",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n__MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4:\nAEsRow 5:\n__ELDERM3_",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSRow 4:\n Row 5:\nRRow 6:\nQOL ( row row 7: ety row 8:Row 9:\n Row 10:\nS row 11:Row 12:\nR row 13: s row 14: L row 15:Row 16:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 7)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\nI: 12·0 (IQR 6·5 15·7)Raw 6: ~Row 7:\n(will ted ly)ROW 8: 126/ 2 (1/ 4 17·4)Rov 9: −Row 11:\nrod rod -4 (95% row 47): row 48*. Row 24; row 24 *24(0)Row 24:\nrow 14, row",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nRoad 5: ROW ROW 6: recurred, or/_MEDTERM0(bid bid N=172Pemetrexed 500 mg/m2 + cisplatin 75 mg/ m2 ? mg mg / m2 for) {MM-YY} was was 78% group. group.'Row 33:\n Row 34:\nvs. vs.>METM3_# RowRow 35:\non on 23-01-2025",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\ndied died (30% and and 37% in the_ verwarreneterM1( 35 35 (33.7%) 37 37 (35.9%) monthmeters monthmeters (95% CI: 26.4not reached) rate against the",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\nor or __MEDTERM0_",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: (generation generation TKI)' ROW 2: survival survival (___MEDTERM22_) equal equal to% the the ,45m- a a __",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: ROW 2: ROW 3: ROW 4:Row 5:\nROW ROW 6: analysis (in in the__METERM1_group). evaluable evaluable (95% CI 20·3NE) versus versus 10·2 months (8/212·0)with _MEPTERNIM1_ (HR 0·34 [99 rapportages ratio%%% powder/kg/day.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\ncrizotinib (generation generation TKI'Row 2:\nrate rate (___EDTERM9_) - RowRow 3:\nPeng Peng (2023) __MENTERM9_ __MENTERM9_ (Figure 3). and and //CEDTERM1+.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nrow 6: -Row 7:\nresponse response rate-chemotherapy chemotherapy or",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: __MEDTERM0_ (generation generation TKI'Row 2:\n Row 3:\nAdverse events (AEs) Grade-≥3 - Imported outcomeRow 4:\nPeng Peng (2023) grade grade ≥events events graded_",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n__MEDTERM0_ __MEDTERM0_ (when",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: generation generation TKI) of of grader/RowRow 2:\nlife life (by by partner'reported. reported.' ROW 10: ROW 11: study, Solomon",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: RowRow 5:\nRoad 6: Peng Peng (2023). ~",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 330/428",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading _MEDTERM0_:",
      "text": "Row 1:\nRowRow 2:\nRowRow 16:\n Row 17:\nConsideration ROW 18: ~ ROW 19: necessityM8_ necessityM8_ (radiomegaly) mutationsRow 20:\nincurable__ VNEDTERM12_(radio geëlimineerd) prednisone. prednisone. Roww",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: Road 6: ~ with with nonsmall- stage stage IIIB/ a a tar_",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: ROW 2: NCT01395758 Gerber (2018) arm arm (HRRow 11:\n Row 12:\non on 23-01-2025 332/428",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4:Row 5:\n• carcinomaROW carcinomaROW 6: 1.20; 95% CI: 0.761.88; P=0.44). relevant. relevant. • Rome 7: survival survival - Imported outcomeRaw··5: survival survival (_MEDTERM14) row row 20: row 21: Adverse events - Imported outcomerow 22: Events Events (AEs).'Row 23:\ńRow 24x26 Rovracht-Rovert-Row",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nrow 4: RowRow 5:\nRoad 6: following following outcome: status status (HR 0.69; 95% CI: 0.530.91), physical functioning (0.59; 0. 0.92), dyspnea dyspnea (0.63; 95%CI: 13, 13,",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 334/428",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading _MEDTERM0_:",
      "text": "ROW 1: ROW ROW 2: __MEDTERM1_fusesRow 3:\nRoad 4: Raw Raw 5:Row 6:\nWhich (new) at at _MEDRM1_fusions? arrow arrow 8: row row 10: incurable incurable ~_Row_rm3 _Row_rm3 Rawd-Meier",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading _MEDTERM0_:",
      "text": "ROW 1: 2023), RowRow 2:\nof of __ELDERM7_+__. Both {MEDERM00] and {IMDERM1+] received a {MMD]-naïve to Rodder'Netherlands, ___EDTERTM% was {mgD = 2] available. available. {",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nrow row 3: row 4: row row 5: trials trials (RCTs) Road Road 6: ROW 7: 8 8 : ~ Late Late ≥ 12",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 336/428",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nRowRow 4:\nRowRow 5:\nrow 6: row row 7: __MEDTERM0_ __MEDTERM0_ (rarely) mutations.Row 9:\n(rasle) mutations(sleep)-Raw 10: *Row 11:\nRidgeRow 12:\nLate 13 ROW-12:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: trials trials (RCTs) RowRow 5:\nrow 6: −Row 7:\n~Row 8:\nRow",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\nRowRow 2:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\nrow row 15:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\naber __MEDTERM0_ROW 9:Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\nRowRow 15:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\n Row 6:\n Row 7:\n Row 8:\nC __MEDTERM0_",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n336/428",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading _MEDTERM0_:",
      "text": "ROW 1: RowRow 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nRaw 6: Which (new) patients patients met_MEDERM13_+enrolled enrolled (treated treated __MElderM15;__METERM0_), was the ___MEderM46_67%, obtained obtained (Fan, 202463). well. well. {months/months-",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\n Row 2:\nrow row 3: row row 4: row 5: row row 6: trials trials (RCTs) Road Road 7: ROWTER-MEPTER-8 Lately Rowter-9",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 338/428",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nRowRow 6:\nrow 7: row row 8: 14__MEDTERM0_ 14__MEDTERM0_ (rarely) mutations. Road 10: (raswolf) mutations arrow 11: ~ row 12: selection selection 14_",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\ntrials trials (RCTs) ROSRaw ROSRaw 6: ROW 7: ~Row 8:\n−Row 9:\nRow",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 2)",
      "text": "Row 1:\nRowRow 2:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\nRowRow 16:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\n Row 9:\nabble_MEDTERM0_ Road 10:Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\nRowRow 16:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\n Row 9:\nC met",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed ___MEDTERM0_: (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n338/428",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed Which (new) HER2 HER2 mutations?",
      "text": "Row 1:\nrow row 2: row row 3:Row 4:\nrow row 5: row 6: Which (new) HER2 HER2 Mutations? ROW 8: arrow arrow 10: the the following:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "headed headed Which (new) HER2 HER2 mutations?",
      "text": "ROW 1: 2023), RowRow 2:\noutcomes outcomes (Jebbink, 2020). __MENTERM3_% of of 28% (95% CI 19% - 38%), a median ___",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "headed headed Which (new) HER2 HER2 mutations? (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nrow 4: analysis. analysis.'Row 5:\nRoad 6: RowRow 7:\nWu (2022)",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed Which (new) HER2 HER2 mutations? (from previous page)",
      "text": "Row 1:\n Row 2:\nrow row 3: row 4: and and select;_",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed Which (new) HER2 HER2 mutations? (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 340/428",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed NRG:",
      "text": "ROW 1: RowRow 2:\n__MEDTERM2_/ RowRow 3:\n Row 4:\n• wish wish • Raw Raw 6: • Which (new) spp spp • 2nd use • Worse • Who cares? • Raw 8: raw raw 10: incurable incurable ~_MED_Wors",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "headed headed NRG:",
      "text": "ROW 1: 2023), RowRow 2:\nby by program-",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "headed headed NRG: (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: 2021). @around around 25%, months months (Drilon, 2021):Row 7:\nUndergoingRow 8:\nRoad 9: Conclusions ROW 10: ~ ROW 11: ́Resistance with TAR(S)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 342/428",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 1)",
      "text": "Row 1:\n Row 2:\nrow row 3: 2021). around around 25%, months months (Drilon, 2021).Row 4:\n Row 5:\nUndergoingrow 7: Vertel 8: Conclusionsrow 9: −Row 9:\n-version version Rowver'other. other.",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nothera row 10:Row 11:\n Row 12:\n Row 13:\n Row 14:\ntment .Row 15:\n Row 16:\n Row 17:\n Row 18:\nincura row 19:Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\nprodu row 25:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\nRowRow 15:\n Row 16:\n Row 17:\n Row 18:\nabble__MEDTERM0_ROW 19:Row 20:\n Row 21:\n Row 22:\n Row 24:\nRowRow 25:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\nRowRow 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\nRowRow 15:\n Row 16:\n Row 17:\n Row 18:\nC __MEDTERM0_",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed NRG: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n342/428",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed Which (new) _MEDTERM0_ _MEDTERM0_ mutations?",
      "text": "ROW 1: RowRow 2:\nRowRow 3:\nROW 4: Raw Raw 5:Row 6:\nWhich (new) at at _METM1_fusions? ~ ROW 8: row row 10: module module treatmentnummer_",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "headed headed Which (new) _MEDTERM0_ _MEDTERM0_ mutations?",
      "text": "ROW 1: 2023), RowRow 2:\ngoal-directed goal-directed ___",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "headed headed which (new) _MEDTERM0_ _MEDTERM0_ mutations? (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nConclusionsRow 4:\nrow 5: -with with __",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed which (new) _MEDTERM0_ _MEDTERM0_ mutations? (from previous page)",
      "text": "Row 1:\n Row 2:\nrow row 3: row 4: Which (new) at at __MEDTERM0_% mutations? row 5: incurable___ELDTERM2_ incurable___ELDTERM2_ __QDTERM1-1_(rarely) mutations.",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed which (new) _MEDTERM0_ _MEDTERM0_ mutations? (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 344/428",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed BRAF V600:",
      "text": "ROW 1: ROW ROW 2: RowRow 3:\n Row 4:\nRaw Raw 5:Row 6:\nin in BRAF? ROW 7: ́ ROW 8: WW WW 10: WW_M15_ WW_M15_ (zeildworm) a a __MEDTERM0_//study study (59 patients) a a ~from from 63% months months (Planchard, Besse, 2016).' ROW 29: ROW 30: review review plus",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nROW ROW 4: Road 5: Raw Raw 6: the the short__",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 346/428",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "ROW 1: ROW ROW 2: mutations mutations /Pharmacy Pharmacy Rawder-Mothers-Personal Retardation Rowter-Mateler-Wadeler-Two-Doseler-Sider-Rawter-Line Rawter-Line . Raw",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "ROW 1: 2023), RowRow 2:\nconcerning concerning first-and and __EDTERM16__Study: concern concern first-",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\nlung lung carcinoma' ROW 4: chemotherapy chemotherapy (for __EDER_M0_0.25) was reported (Jänne, 2023);RowRow 5:\nRoad 6: UndergoingRow 7:\n~Row 8:\nConclusions ROW 9: ́Row 10:\n− with with tar_",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "headed headed BRAF V600: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 348/428",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading board board __MEDTERM0_",
      "text": "ROW 1: ROW ROW 2: RowRow 3:\nROW 4: Raw Raw 6: board board (MTB) are: ROW 2 mg/ used used instead? MTB MTB managed? 3 3 mg/ Roy Roy 25: Raw Raw 26: ~RowRow 27:\nbetreffende - row 28: r aw 29: network network for:Roow 30: rod- to to ROW-",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 2:\nRaw 3: RAY RAY 4: RowRow 5:\na a (regional) row row 7: RowRow 8:\nthe the following: nurse nurse (Basse, 2018; Rofo, 2018). DNA DNA technology",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nsituation situation (Velden, 2017). sequencing sequencing (WES) sequing sequing (WGS) a a (molecular) patient'RowRow 7:\n Row 8:\nwell well as",
      "start_page": 351,
      "end_page": 351
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Raw Raw 7: demonstrate demonstrate case-cancer cancer (Lindeman, Lindeman, 2018; Garinet, 2018). frequent frequent (mean >5%) domains domains (__MENTERM2_exon19del, __MENTERM2_exon19del, _",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nnon-useable row 4: cancer cancer ́Row 5:\nTsao, 2016;timally, 2013). MTB-mediated MTB-mediated mutation-",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: ROW ROW 5: therapy therapy (not not registered/off-label) melanoma melanoma (than than V",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\nfindings. findings.",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nBoards (MTB) RowRow 6:\nRrow 7: RowRow 8:\n~Row 9:\nrow row weekly",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\non on 23-01-2025 355/428Row 2:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nKinase Kinase Inhibitors: Diagn Diagn 2018;20: 129-159.Row 6:\n1",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n23 - Oncol Oncol 2016;11: 613-638.Row 2:\n2",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 356/428",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma -Rrow Rrow 3:Row 4:\nthe the care/ Rod Rod 18:Row 19:\ntreatable treatable risk-significant significant risk/ benefit",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n• cancer cancer •Row 4:\n• efficacy. efficacy. • as as follows: • areas areas • care care • community community • RowRow 23:\n Row 24:\nCare Care (PSURs) as as follows: pharmacovigilance pharmacovigilance activities",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: lungrow lungrow 5: arrow operation 6: row row 7: Adamson Adamson (and and 2011)Row 9:\n−Row 10:\n•Row 11:\nand and Row",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n Row 6:\non on 23-01-2025 359/428",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n1- Palliative Palliative care: The The Hague: 2007.Row 4:\n2",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n3- IKNL Pallialine URL: https://www.pallialine.nl/ RowRow 2:\n4",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n12 - The The Hague: 2011.Row 2:\n1",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 360/428",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nROW ROW 2: RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\ntherapy therapy : ROW: condition condition ~_METM0_ THORCULAR COMPLICATIONS: to to Row'RowRow 21:\ndose dose (3 3 Gy) considered considered and;discussed discussed (sheared decision making). Row-",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: row row r/ high-grader high-grader R/ very very low- grade 3R/ Rov Rov 21:Row 22:\nof of <ROW ROW 23: 3; rod. rod. r/ radiotherapy radiotherapy (in in maintaining",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1:Row 2:\nROW 3: row 4: Road 5: Raw Raw 6: of of {mg/kg/day}",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\narrow 3: row 4: RowRow 5:\n6 6 201420082006(Gy Gy (1fx) Gy Gy (10vx)studies. studies.'Row 39:\nof of 3/and and 2/RowRow 40:\n Row 41:\non on 23-01-2025 364/428",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n2014Row 4:\n Row 5:\nGy Gy (1fx) Gy Gy (10vx)xRow 6:\ncattle cattle 7: Gy Gy (2fx): vs.-30 Gy (10fx), Gy Gy (2vx/ gx) • Rowx 12 grx",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\nrow row 3: 2008 row 4: row 5: x row 6: ~Row 7:\n{row 8: }",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 3)",
      "text": "Row 1:\n Row 2:\nLesterRadiatestecRow 3:\n(maximal row 4: 2006(maximum row 5: RowRow 6:\nRowRow 7:\nrod 8: x-2DRow 9:\nrow 10: Raw Raw 11: ~Row 12:\n+ 2arrow 2arrow 13: −Row 14:\n2arrow 2arrow 22:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 4)",
      "text": "Row 1:\n Row 2:\nchnic",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 25: row 26: row 27: rotation. row 28: row 29: row 30: row 31: , it. it.",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: ROW ROW 5: complaints complaints (0. 0.89; 95%67-1. 67-1.18) symptoms symptoms (1. 1.00; 95%89-1. 89-1.12) ongebruikteRow 19:\nsymptoms symptoms (17 Gy: 83.3%; 20 Gy: 79.6%; 30 Gy: 87)EKENRow 20:\n Row 21:\nHemoptoeRaw 22:",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRoad 4: • ROW ROW 5:Row 6:\n7 7 : rate rate (1. 1.28; 95% 03-1. 03-1.60), survival survival (1. 1.38; 95%94-2. 94-2.04) dose dose (dose dose (<30 Gy) combinations combinations ___MEDTERM0_/ improvement improvement (obstructive obstructive pneumonia) Road Road 19:Row 20:\nmetrie -Roy -20: Roy-2-20:",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 366/428",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nlung lung carcinoma'Row 3:\n Row 4:\nOncol. Oncol. 2008;26(24):4001-11. [link]Row 5:\n2 - Reviews. Reviews. 2006;4(4):CD002143. [link]Row 6:\n3 M-M-K-C-H-G.",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nOncol. Oncol. 2008;26(24):4001-11. [link]Row 5:\n2 - Reviews. Reviews. 2006;4(4):CD002 1443. [link]' Row 6; 2014 c-",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\n Row 5:\nne DatabaseRaw 6: locallyRrow locallyRrow 7: nd lowerROW 8: raneRown 9: hedule of 1(4):348-53.'Row 10:\n189-202. 189-202. [link]'ROW 11: link]Row 12:\nrow row 13: ~Row 14:\n367/428",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "carcinomaROW carcinomaROW 2: communicationRaw communicationRaw 3:Row 4:\nUse Use (CHMP) Row Row 6? the the benefit/their their notification: https://isbg.nl/lung cancer-by-asbestos/.",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nRecommendation row 5: row 6: • on on diagnosis? Road 7: ● occupational occupational disease? −Row 8:\n- informed informed ___~ Diergeneeskunde Diergeneeskunde Nijde-Jedschappelijk-Diaanwerk Intensie Tel: +99 99 België/ Belgique/ Belgien Raw-Targaal-Row-Raw-this this medicine",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow 4: row 5: row 6: row 7: row 8: row 9: __SCLC?Row 10:\nrow 11: row 12: row 13: row 14: row row 15: row 16: row 17: row 18: row row 19: row 20: row 21: row 22: row 23: no row 24: row 25: row 26: row 27: row 28: row row 32:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "the the benefit/ Row Row ́RowRow 18:\n Row 19:\nRaw Raw 21: MEDTERM MEDTERM 0/ 2",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 2:\nrow 3: row 4: Rav 4: arrow arrow 5: RowRow 11:\n Row 12:\nRoad Road 13: work work (Baars, 2005). and and asbestos",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: ROW 2:Row 3:\n• cancer cancer • ROW 4: • excluded excluded • claim. claim. • 13 13 • Draw-assessed Draw-assessed • disease disease • Working Group • pregnant pregnant • claim claim • Raw Raw 16:Row 17:\nthis this risk/ cancer cancer (Lexces, 2022). foetus foetus and",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "RowRow 3:\n Row 4:\n• cancer cancer • the the treatment/ risk/ benefit/ ROW ROW 7: treatROW treatROW 8: an an option; whether whether he/ RowRow 15:\n Row 16:\nUndergoingRow 17:\n Row 18:\nBackgroundRow 19:\n~Row 20:\nwith with the",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\ngroup. group.",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n2- patients. patients. Tilburg: RowRow 2:\n3",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 373/428",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "for for human",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 374/428",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "important important (risk risk minimisation) ng ng • activities activities • years years • RowRow 17:\n Row 18:\nConsiderationsRow 19:\n-Row 20:\nRoad Road 21: ~Row 22:\nUndergoing",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 375/428",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - communication communication - Rrow Rrow 3: Raw 4: RowRow 5:\nRoad 6: contact contact ~patients patients {>others others ́ patient patient ́patients patients ́ Cancer Cancer Foundation;_EDERTERM0_volunteers.Row 21:\n Row 22:\nResponsibleRow 23:\n~Row 24:\nLast assessed: 07/07-2020Row 25:\nLast authorized: 07-07-2020",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 376/428",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: RowRow 5:\nProfessional. Assen: RowRow 6:\ncancer. cancer. Tilburg: RowRow 7:\n Row 8:\non on 23-01-2025 377/428",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\npro.Asses: 175-1Row 175-1Row 4:\nrow row 5:Row 6:\non on 23-01-2025",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\nrow 3: RowRow 4:\nRowRow 5:\nRoad 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow row 5:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\notencoRow 5:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nnkerpatRow 5:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nurg: RowRow 5:\n Row 6:\n377/428",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - RowRow 3:\n Row 4:\nBaseline questionRow 5:\nRoad 6: cost-effective cost-effective ---therapy therapy (tumor tumor recurrence) ?Row 7:\ńRow 8:\nRecommendationROW 9: ~ROW 10: ___ROW a &RowRow 22:\n Row 23:\nunknown. unknown.",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\ncarcinomaROW carcinomaROW 5: whereas whereas FDG-PET/from from Row-Tr(s) Raw Raw 14:Row 15:\ngroups, Row-in in patients",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nthorax thorax (contrast contrast administration).Row 6:\nRow 7_: scan scan 16:Row 17:\nUndergoingRow 18:\n Row 19:\nBackgroundRow 20:\n Row 21:\ncarcinoma carcinoma (___EDTERM12_) intention intention (SBRT, surgery and/or chemodiation): or or FDG-curative curative treatment? the the patient's condition?",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: RowRow 4:\nPET-CTRow 5:\nusing using FDG-PET/FDG FDG -PET/18 18 . survival survival (Crabtree, 2015; Karzien, 2016; Reddy, 2017).'Row 33:\n Row 34:\nof of FDG-PET/36 36 :",
      "start_page": 381,
      "end_page": 381
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: lung lung carcinoma' ROW 6: examinations and (follow-up) diagnostic imaging. ́Row 7:\n Row 8:\nsurgery surgery (Chiu, 2003; Crabtree, 2015; Onshi, 2011; Takenaka, 2010); RowRow 21:\nRowRow 22:\n Row 23:\n~ ROW 24: −ROW ROW 25: postoperativeations postoperativeations ~_",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: ROW ROW 6: resection resection (stage I-IIIA) 1.FDG-PET/CTpathological (if feasibility) examinationsRow examinationsRow 7:\nexams exams (incl non-contrast CT) CT CT (n=46)Row 28:\n Row 29:\ńRow 30:\n\\diseaseRow 31:\nsurgery surgery (n=33),radiotherapy radiotherapy (n=10) therapy therapy and/or chemotherapy (n=2)CTpathologyRow CTpathologyRow 32:\n'Row 33:\n~T. T.",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: ROW ROW 5: Road 6: consciousness consciousness (the the test) . for for FDG-PET/38. 38. Nakajima",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nROW 3: row 4: row row 5: I I ́R. R. 0",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nRowRow 5:\nRowRow 6:\n Row 7:\nFDG-PET/RowRow 8:\nRowRow 9:\ńRow 10:\nRowRow 11:\nOnishi 2011**121Row 12:\nRow necessity:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\nassessed assessed (04%) (0* Methode-(0))(0*)(0)20*(0)(0)1(0)2(0)2)(0)4(0)? Row.0*, 10*, 12*, 20*, 13*, 19*, 28*, 30*, 17*, 31*, 16*, 24*, 08*, 9*, 14*, 49*, 48*",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 3)",
      "text": "Row 1:\n Row 2:\nve results PET/CTRow 3:\nrow 4: Road 5: RowRow 6:\n~Row 7:\n{row 8: } Row",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: lungarrow lungarrow 6: 73 73 (0.43- 0.090)0.91 (0.83- 0.96)RowRow 7:\n Row 8:\nsurgeryraw surgeryraw 9: 21 21 (0.04-0.0)-(0.49)-",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n(Number FP + number TN)Row 2:\n**) many data reported; here results from: assessed assessed FDG-PEGT/CTRow 3:\n***) TN, TP; these acrachy",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\ndata fit FN=1, TN = 21 (total n=44)Row 2:\n**) treatment, SUVmax>RowRow 3:\n*** late late images; SUVmax 4.'and and 5: Results: and and Karzien(0) months. months.'Row 13:\n Row 14:\nRowRow 15:\naccuracy accuracy / limitations limitations (risk of bias: physician. physician.",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3:Row 4:\nROW ROW 5: Road 6: limits limits (risk of bias; retrospective observational studies) and uncertainty (imprecision; following following criteria: investigating investigating FDG-PET/CT, CT and/Rodwell Rodwell ́ Tel:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 387/428",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n Row 5:\nlung lung cancer? Surg. Surg. 2015;149(1):e1-3. e1-3. doi: 10,1016/RowRow 6:\n3",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 388/428",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nof of \"organization and care\" modules. modules.'Row 5:\nthese these (sub) modules. row 6: row 7: Responsible row 8: ~ row 9: Last assessed: 22-05-2011 row 10: Last authorized: 20.05-2011",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 389/428",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer - RowRow 3:\n Row 4:\nof of \"organization and care\" row row 5: this this (sub row 6: row 7: Responsible row 8: ? row 9: Last assessed: 22-05-2011 row 10: Last authorized: 20.05-2011",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nodulesRow 5:\nb)modRow 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nvervainRow 11:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 3)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\ns.'Row 5:\nduels.'Row 6:\nROW 7: ~Row 8:\n{Row 9:\n}Row 10:\nante prow 11:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 4)",
      "text": "Row 1:\nrow 2: row 3: row 4: row 5: . row 6: row 7: row 8: row 9: row 10: produ row 11: row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nrow 4: row 5: row 6: row 7: row 8: row 9: row 10: guess row 11: row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\nRowRow 11:\n Row 12:\n389/428",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Raw Raw 2: carcinoma carcinoma - RowRow 3:\nROW 4: weeks weeks . ROW: for for patients? Level Level 2: 2002 2002 (7), Jones), 1994 (20), Rapoport 1993 (23), 1976-77 1976-77 (24) Grade Grade 2: 1994 1994 (4), Bozcuk 2001 (9), Billing 1996 (10) treatment treatment (dose dose radiation) Level Level 3: 2000 2000 (8)Row 29:\nPDF",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "following following procedures:Row 3:\nrow 4: the the test: patient patient ́Consultation Consultation ( etc, collaborating), proposed proposed (see table below) (1). Table: Care Care (2)Row 18:\n Row 19:\non on 23-01-2025 391/428",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "given given to: patient patient ́at at 25°weeks weeks (5). to to be: (a) pulmonologist. pulmonologist. (b) week. week. (c) hours hours (of of maximum) s s symptoms",
      "start_page": 392,
      "end_page": 392
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n(g) begin begin (is is acceptable) (6). table table (see Appendix) (7) (8) (10) (11) (12) . the the radiotherapist'days days (median: 44). of of 0-373% (median : 56) In In 21% RowRow 7:\non on 23-01-2025 393/428",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row-Raw Row-Raw 3:Row 4:\nrow 5: Raw Raw 6: treatment treatment (high-dose high-dose ventilation) in in patients;differences differences between",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\ndatabase. database. ́Row 2:\n Row 3:\nreferringRow 4:\nrow 5: 1 - c. c. • lilly lilly Tlf: • Row-Raw-Rac-Rav-Rov-Ra-Rad",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n1",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nMedicine 152;2714-2717Row 2:\n1",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 395/428",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nrow row 5:Row 6:\nconsultation consultation (MDO) met_ met_ __ELDERM2___?Row 7:\n Row 8:\nRecommendationRow 9:\n Row 10:\nIII III );",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: a a (eventual) medical medical counselor'a a physician'compassionate compassionate care/patients' a a doctor'the the patient'the the physician'the the decision-to-be-therapist'to to continue",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: Road 5: row row 6: the the discussion: row 7: − row 8: • physical physical examination; further discussion: assessment assessment are: be be re-evaluated:",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nResponsibleRow 3:\nrow 4: Previously assessed: 22-05-2011Row 5:\nLast authorized: 12-05-2011",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 397/428",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: RowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nRoad Road 5:Row 6:\nmet met (suspected on) ~Pulmonary: #Roval: #Tolerating the lung'lung. lung. #Row 7:\n Row 8:\nConsiderationsRow 9:\n Row 10:\ndescribed. described. #Row 12:\nBuildingRow 13:\n Row 14:\nControl Control (June 2010) rate rate (73 73 (95% CI., 0.64 - 0.84, p<0.001) survival survival (93 93 (95%84-1. 84-1.03; p=0.16) (4) rate, rate,",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow 4: Road 5: of of thoracic/ NSCLC NSCLC (period 2001-2006). specialists specialists (\"RowRow 8:\n Row 9:\nResponsibleRow 10:\n?Row 11:\nLast assessed: 22-05-2011Row 12:\nLast authorized: 22.05-2011",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n3Row 2:\nJAMA 280:1747-1751Row 3:\n4",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nOncol Oncol Suppl1: s83-92Row 2:\n6",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 399/428",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n8",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n11 - 'care. care. Utrecht:'Row 2:\n Row 3:\non on 23-01-2025 400/428",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\nRowRow 2:\n8",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 1)",
      "text": "Row 1:\n11 - 'care. care. Utrecht:'Row 2:\n Row 3:\non on 23-01-2025",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRowRow 4:\nRowRow 5:\n Row 6:",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (column column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\ngeal resection: RowRow 4:\nRowRow 5:\n Row 6:\n Row 7:\n400/428",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Rov 1: Rov Rov 2: cancer cancer - RowRow 3:\n Row 4:\ngiven given to: Raw Raw 5:Row 6:\nThis This includes: Row 7; as as follows: Rov 8: Row Row uc",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\non on 23-01-2025 401/428",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "a a centre:Row 16:\n−Row 17:\ncare care − Care Care − of of dual-agent/ therapy therapy . Examples Examples are: techniques, (adjuvant) RowRow 21:\nRowRow 22:\non on 23-01-2025 402/428",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: arrow 5: RowRow 6:\n~ of of Row",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n6Row 2:\nJAMA 280:1747-1751Row 3:\n7",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 403/428",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: RowRow 2:\ncarcinoma carcinoma - RowRow 3:\n Row 4:\nRowRow 5:\n Row 6:\nmet_ met_ __MENTERM6_?Row 7:\n Row 8:\nConsiderationsRow 9:\n Row 10:\nRowRow 11:\n Row 12:\nBuildingRow 13:\n Row 14:\nRowRow 15:\n Row 16:\nthe the patient'of of patients;protocols protocols (Surgeons Surgeons database) of of text",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: cancerarrow cancerarrow 5: COPD COPD (1). trials, co- independent independent prog",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nlength (in cm);Row 3:\nweight (in kg); row 4: performance-score performance-score (Karnofsky/ WHO), see table ( 8) ( 9)Row 5:\ncirculation: venegraphy venegraphy (superior superior syndrome) lymph node stations; row 6:",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: row 4: row row 5: row row 6: row 7: status-Raw status-Raw 8: RowRow 10:\nup up to",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRed chest X-ray;Row 3:\nBronchoscopy;Row 4:\nCT;Row 5:\nmediastinoscopy (these these glands);Row 6:\n~FDG-PET or FDG- PET-CT; Road 7 MRI; PA PA testing; Laboratory Laboratory examination; 13 13 ROB: UV UV Rob:",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nRoy 3: row 4: ROY 5: lungRaw lungRaw 6: Wow 7: ?vital capacity (VC));",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\ndate of surgery;Row 3:\ntype of operation;Row 4:\nradiation radiation therapy;Row 5:\ndose (in Gy) radiation radiation radiotherapy;Row 6:\n• dose dose adjustment;Row 7:\n● of of chemotherapy;Row 8:\necombinant chemotherapy type;Row 9:\n− chemotherapeutic chemotherapeutic agent;Row 10:\nadequaat: Row 13 − weight weight adjustment; Row 15 − platelet",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nor or progression;Row 3:\ndeath date; row 4: RowRow 5:\nRoad 6: ResponsibleRow 7:\n~Row 8:\nLast assessed: 22-05-2011Row 9:\nLast authorized: 20.05-2011",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 407/428",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: 5- cancer. cancer. 'Laryngoscope 110:593-602', 2000.Row 5:\n6",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nCriteria. Criteria. 'Version 2.0'. RowRow 2:\n Row 3:\non on 23-01-2025 408/428",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "is is 1: ROW ROW 2: cancer cancer - RowRow 3:\n Row 4:\nOncoline Oncoline - RowRow 5:\nrow 6: breast breast cancer; pain pain severity",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\nrow 5: 1- 2008 2008 Feb;24(1):57-67.Row 6:\n2",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 409/428",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - RowRow 3:\n Row 4:\nOutpatients' Raw Raw 5: row 6: patients patients met_READERM14_? raw raw 8: RecommendationROW 9: ~Row 10:\npatients patients ___>patients patients __MDTERM0; lung cancer, 37% problems problems (4). anorexia anorexia (1).Row 26:\n Row 27:\nResponsibleRow 28:\n~Row 29:\nLast approved 2205-2015:",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading board board __MEDTERM0_ (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\non on 23-01-2025 410/428",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "headed headed References",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\nrow 5: 1- cancer. cancer. In: Holland JC (ed). Psycho-Oncology. New York: RowRow 6:\n2",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References",
      "text": "Row 1:\n3Row 2:\nPsycho-oncology 10:19-28Row 3:\n4",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 411/428",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nRowRow 4:\nrow 5: 1- RowRow 6:\n2",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 1)",
      "text": "Row 1:\nOncol Oncol 18:Row 2:\n3- RowRow 3:\nPsycho-oncology 10:1Row 4:\n4",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 1)",
      "text": "Row 1:\n Row 2:\nat at 23-0",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 2)",
      "text": "Row 1:\ninoomRow 2:\n Row 3:\n Row 4:\n Row 5:\ncer. In: Holland JC (ed). Psycho-OncoRow 6:\nlu lu :RowRow 7:\n.893-903Row 8:\nRowRow 9:\n19-28Row 10:\nbikka bikka Utrecht: Row",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nology. New York: Oxford row 6: ung cancer: row row 7: RowRow 8:\nrow row 9:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nRowRow 7:\nRowRow 8:\nRowRow 9:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n340-34Row 6:\nRowRow 7:\nRowRow 8:\nobletRow 9:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\nrow row 7: RowRow 8:\nRowRow 9:\n Row 10:\n411/428",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - Rrow Rrow 3:Row 4:\nthe the nurse'during during treatment? child child Discontinuation;support support _",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nadvanced advanced __",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\non on 23-01-2025 413/428Row 2:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nlife life (6). study study (n=59) chemotherapy chemotherapy and/therapy therapy (7). the the patient'chemotherapy chemotherapy (10). study study (n=471) nurse nurse (11). following following symptom",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Use Use (CHMP) of of any",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\nRoad 5: 1- care, http://www.oncoline.nl/2010Row 6:\n2",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n2011; ANNONC-2010-0749Row 2:\n7",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 415/428",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n8",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n10 - lung lung cancer: approach. approach. 'RowRow 2:\n1",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\nRowRow 2:\n13 - work. work.http://www.oncoline.nl/cancer-RowRow 3:\n14 - 2010, http://nl nl / Roy 4: 1",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n2011; ANNONC-2010-0749Row 2:\n16 - cancer. cancer. '2008 2008 Feb;24(1):57-67'.Row 3:\n1Row 4:\nhttp://www.stivoro.nl/Professionals/Setting/Care/Guideline_Treatment_of_tobacco dependence/Road Road 5:Row 6:\n2301-2025. 2301-2025.",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Organization Raw 3:Row 4:\nLevel Level 3: 1992 1992 (1) Caregivers Caregivers (mental mental caregivers) Level Level 3: c Schrameiwer (1)Row 22:\nrow row 23: row 24: row row 25: - row 26: 27 27 - 4:25 - 4:35PM.",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 2:\nthis this risk/ complaints complaints and/refer refer (1) (2). as as (medical) Room Room 9",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nReferencesRow 4:\n Row 5:\n1 - RowRow 6:\n Row 7:\non on 23-01-2025 418/428",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nNcGv series: 92-22. Utrecht: RowRow 5:\n2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\nESF. ESF. 'Guideline Oral Cavity/ Oropharyngeal Carcinoma(concept).Row 2:\n Row 3:\non on 23-01-2025 419/428",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nNcGv series: 92-22. Utrecht: Road Road 5: 2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (column column 1)",
      "text": "Row 1:\nESF. ESF. -GuidelineRow 2:\nRoy 3: on on 23-01-2025",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:\nn Oral cavity/OropRow 7:",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (column column 3)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\n Row 5:\nhelp? In: in in oncology; manualRow 6:\npharyngeal carcinoma(concept).Row 7:\nrow 8: 419/428",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "ROW 1: ROW ROW 2: small small - Rrow Rrow 3:Row 4:\nRowRow 5:\nrow 6: performance performance status? Raw 8: Road Road 10: tumors tumors > but but ≤ of of > RowRow 22:\n Row 23:\npartial partial atelectasis/ TNM7 TNM7 . T4 T4 (was previously T",
      "start_page": 420,
      "end_page": 420
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\nrow 5: Road 6: lung lung setting: the (maximum length), directions directions (or or coronal) Raw Raw 7:",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row 4: row row 5: c) lesions lesions {lesion lesion *for for multiplicity; row 6: d) tumour tumour (similar SAE-M0/ b (see above)) defined defined as",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\ninvasive adenocarcinoma. (Bron: Travis, 2016)Row 2:\nt-statusCategorieRow 3:\nAISTisRow 4:\nMIAT1miRow 5:\n≤RowRow 6:\n>1-2cm'T1bRow 7:\n>2-3cmT (1cRow 8:\n13 PL1/PL2T2 ROW 9: >3-4cm 'T2aRow 10:\n>4-5cm Tow 11: PL3T3 Road 12: >557* Rowwind in the",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\nRoad 3: RowRow 4:\nrow 5: Raw 6: N-statusRow 7:\ninvasion invasion (Table 2). area area .",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nROW ROW 4: classification classification (Bron: Raw Raw 5: Rrow Rrow 6: hilar hilar and/ Road Road 8: N2 Gland metastasis",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed References (column column 1)",
      "text": "classification classification (Bron: Asamura, 2015) 45 45 mg/ view view of",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed References (column column 2)",
      "text": "Row 1:\nrow 2:Row 3:\n Row 4:\nROW 5: ROW 6: ~Row 7:\n−Row 8:\n4)Row 9:\n●Row 10:\ne-d, grofRow 11:\n♦Row 12:\ninRaw inRaw 13: →Row 14:\n↔",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\nRaw 3: ROW ROW 4: • metastases metastases • ROW 1/ Trough Trough 18B- IIIR-IIIR- Trough 15B-8B- or 8B-L-III. • Rough Rough 7: M1bSolitary M1bSolitary extrathoracic(s) RowRow 33:\n Row 34:\nRod Rod 35: -Row 36:\non on 23-01-2025 425/428",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed References (column column 1)",
      "text": "Row 1:\nRowRow 2:\nmetastasesRow metastasesRow 3:\nrod, o/o, c",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed References (column column 2)",
      "text": "Row 1:\nrow 2: row 3: row 4: rod rod 1/ row row 7: row 8: row 9: IVB IVB (see table 4). row 10: 2. 2.",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\narrow 3: Raw Raw 4: row 5: 3Wot 3Wot 1: rodY rodY rod",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (column column 1)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\naa aa (Detterbeck, 2016).Row 4:\n Row 5:\nRowRow 6:\nRowRow 7:\nRowRow 8:\nRowRow 9:\n Row 10:\nRowRow 11:\nRowRow 12:\nRowRow 13:\nRowRow 14:\nStage ROW ROW:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nrow row 4:Row 5:\nrow row 6:Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 24:\n Row 25:\n Row 26:\n Row 27:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (column column 3)",
      "text": "Row 1:\n Row 2:\nrow 3: arcinomas_",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (column column 4)",
      "text": "Row 1:\n Row 2:\nrow 3: are are cT1a(2)N0Row 4:\nrow 5: 16)Row 6:\nN0 row 7: −N0Row 8:\n=N0arrow 9: >N0 Road 10: phenoxyN0 Raw 11:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (column column 5)",
      "text": "Row 1:\n Row 2:\nrow 3: kt kt __MEDTERM0/ or or cT1b(m)N0M0.Row 4:\narrow 5: row 6; M0Row 7:\ńM0 row 8:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\nrow 3: row row 4: classification classification (8th) row row 5: row 6: selectingrow selectingrow 7: −row 8: age. age.",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\n1",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\non on 23-01-2025 427/428",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed References (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRowRow 4:\n8",
      "start_page": 428,
      "end_page": 428
    }
  ]
}